{"items": "125", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Immix Biopharma Announces Positive U.S. Clinical Data From First Four Patients in NEXICART-2 U.S. Trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory Light Chain  ( AL )  Amyloidosis", "url": "https://www.globenewswire.com/news-release/2024/12/19/2999975/0/en/Immix-Biopharma-Announces-Positive-U-S-Clinical-Data-From-First-Four-Patients-in-NEXICART-2-U-S-Trial-of-sterically-optimized-CAR-T-NXC-201-in-relapsed-refractory-Light-Chain-AL-Am.html", "time_published": "20241219T143500", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 All four patients treated with NXC-201 normalized their disease markers within 30 days of dosing, of which, two are already classified as complete responders ( CR ) , and the remaining two are bone marrow MRD negative ( 10-6 ).", "banner_image": "https://ml.globenewswire.com/Resource/Download/26b9d041-bc90-40a9-8986-b2b5fc82ec28/picture1.png", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.059742, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.246999", "ticker_sentiment_score": "0.051275", "ticker_sentiment_label": "Neutral"}]}, {"title": "Journal of Clinical Oncology Publishes NXC-201 Positive Clinical Results in relapsed/refractory AL Amyloidosis", "url": "https://www.globenewswire.com/news-release/2024/12/16/2997631/0/en/Journal-of-Clinical-Oncology-Publishes-NXC-201-Positive-Clinical-Results-in-relapsed-refractory-AL-Amyloidosis.html", "time_published": "20241216T144800", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022 Chimeric antigen receptor T-cell ( CAR-T ) cell therapy NXC-201 is a novel approach to treat relapsed/refractory AL Amyloidosis \u2022 NXC-201 demonstrated compelling clinical activity, rapid and deep complete responses in frail and resistant relapsed/refractory AL Amyloidosis patients", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.124245, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.29234", "ticker_sentiment_score": "0.089359", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces 75% Complete Response Rate  ( n=16 ) ; 31.5 months Best Response Duration  ( ongoing )  for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2024", "url": "https://www.globenewswire.com/news-release/2024/12/10/2994665/0/en/Immix-Biopharma-Announces-75-Complete-Response-Rate-n-16-31-5-months-Best-Response-Duration-ongoing-for-CAR-T-NXC-201-in-Relapsed-Refractory-AL-Amyloidosis-Patients-at-ASH-2024.html", "time_published": "20241210T143900", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022 75% ( 12/16 ) complete response ( CR ) rate observed in standard of care ( Dara-CyBorD ) relapsed/refractory AL Amyloidosis patients with median 4 lines of prior therapy in updated Phase 1/2 data as of December 9, 2024 \u2022 Best responder duration of response was 31.5 months with complete ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/5c0c18fb-af45-461b-8a4d-2bee733c3198/immix-biopharma.png", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.092767, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.314485", "ticker_sentiment_score": "0.066777", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma to Host Conference Call for Investors, Analysts and Members of the Media", "url": "https://www.globenewswire.com/news-release/2024/12/09/2993841/0/en/Immix-Biopharma-to-Host-Conference-Call-for-Investors-Analysts-and-Members-of-the-Media.html", "time_published": "20241209T143300", "authors": ["Inc.", "Immix Biopharma"], "summary": "- Company management will provide an update on positive new developments regarding CAR-T NXC-201 in relapsed/refractory AL Amyloidosis. Following management's formal remarks, there will be a question-and-answer session.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.088655, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.322549", "ticker_sentiment_score": "0.023607", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Presents Positive NXC-201 Clinical Data at 66th American Society of Hematology  ( ASH )  Annual Meeting in 16 Relapsed/Refractory AL Amyloidosis Patients", "url": "https://www.globenewswire.com/news-release/2024/11/25/2986797/0/en/Immix-Biopharma-Presents-Positive-NXC-201-Clinical-Data-at-66th-American-Society-of-Hematology-ASH-Annual-Meeting-in-16-Relapsed-Refractory-AL-Amyloidosis-Patients.html", "time_published": "20241125T143200", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 75% ( 12/16 ) complete response rate observed in relapsed/refractory AL Amyloidosis patients with median 4 prior lines of therapy \u2022 Data will be presented on Monday, December 9, 2024 at 4:00 PM PT", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.073977, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.329551", "ticker_sentiment_score": "0.050189", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2", "url": "https://www.globenewswire.com/news-release/2024/10/02/2957041/0/en/Immix-Biopharma-Advances-CAR-T-NXC-201-to-Expansion-Cohort-Dose-Level-in-U-S-AL-Amyloidosis-Trial-NEXICART-2.html", "time_published": "20241002T133200", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 Now dosing at dose expansion level of 450 million NXC-201 CAR+T cells.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.123611, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.289576", "ticker_sentiment_score": "0.079998", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board", "url": "https://www.globenewswire.com/news-release/2024/09/19/2949098/0/en/Immix-Biopharma-Announces-Dr-Raymond-Comenzo-Internationally-Recognized-AL-Amyloidosis-Expert-Director-of-the-Myeloma-and-Amyloid-Program-at-Tufts-Medical-Center-Joins-Scientific-A.html", "time_published": "20240919T133100", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine in 2021, resulting in the first FDA-approved therapy for AL amyloidosis \u2022 Dr. Comenzo was the lead author on the landmark 2012 publication of consensus guidelines, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.090199, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.471337", "ticker_sentiment_score": "0.083025", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2", "url": "https://www.globenewswire.com/news-release/2024/08/28/2937104/0/en/Immix-Biopharma-Expands-U-S-Clinical-Sites-for-relapsed-refractory-AL-Amyloidosis-Trial-NEXICART-2.html", "time_published": "20240828T133200", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022 New Sites Expand Opportunities for Patient Access and Enrollment \u2022 Data from ex-U.S. clinical trial reported at ASGCT 2024 showed a 92% overall response rate", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.144604, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.318897", "ticker_sentiment_score": "0.10003", "ticker_sentiment_label": "Neutral"}]}, {"title": "What Makes Immix Biopharma  ( IMMX )  a New Buy Stock", "url": "https://www.zacks.com/stock/news/2323961/what-makes-immix-biopharma-immx-a-new-buy-stock", "time_published": "20240819T160011", "authors": ["Zacks Equity Research"], "summary": "Immix Biopharma (IMMX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default341.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}], "overall_sentiment_score": 0.307181, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.366061", "ticker_sentiment_score": "0.354", "ticker_sentiment_label": "Bullish"}]}, {"title": "California Institute for Regenerative Medicine Awards Funding for CAR-T NXC-201 U.S. AL Amyloidosis Clinical Trial  ( NEXICART-2 ) ", "url": "https://www.globenewswire.com/news-release/2024/07/26/2919333/0/en/California-Institute-for-Regenerative-Medicine-Awards-Funding-for-CAR-T-NXC-201-U-S-AL-Amyloidosis-Clinical-Trial-NEXICART-2.html", "time_published": "20240726T013100", "authors": ["Immix Biopharma", "Inc."], "summary": "$8 million grant funds development of NXC-201 in relapsed/refractory AL Amyloidosis $8 million grant funds development of NXC-201 in relapsed/refractory AL Amyloidosis ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.133304, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.351985", "ticker_sentiment_score": "0.088267", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201", "url": "https://www.globenewswire.com/news-release/2024/07/08/2909719/0/en/Immix-Biopharma-Doses-1st-Patient-in-U-S-AL-Amyloidosis-Trial-with-CAR-T-NXC-201.html", "time_published": "20240708T133100", "authors": ["Inc.", "Immix Biopharma"], "summary": "LOS ANGELES, July 08, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\", \"IMMX\" ) ( Nasdaq: IMMX ) , a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and autoimmune disease, today announced that the 1st patient has been ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.109715, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.295867", "ticker_sentiment_score": "0.083668", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma to Present at the Stifel 2024 Cell Therapy Forum", "url": "https://www.globenewswire.com/news-release/2024/06/17/2899739/0/en/Immix-Biopharma-to-Present-at-the-Stifel-2024-Cell-Therapy-Forum.html", "time_published": "20240617T133500", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, June 17, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" or \"IMMX\" ) , a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced that it will present and host institutional investor meetings ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.016735, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.493666", "ticker_sentiment_score": "-0.022211", "ticker_sentiment_label": "Neutral"}]}, {"title": "RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships", "url": "https://www.globenewswire.com/news-release/2024/06/10/2895991/0/en/RenovoRx-Appoints-Ryan-Witt-as-Senior-Vice-President-Head-of-Corporate-Strategy-and-Partnerships.html", "time_published": "20240610T123000", "authors": ["Inc.", "RenovoRx"], "summary": "New role highlights RenovoRx's commitment to explore and execute on clinical and commercial business development opportunities with its therapeutic technology New role highlights RenovoRx's commitment to explore and execute on clinical and commercial business development opportunities with its ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/e18bf823-ff44-4bbd-82b9-3a311d58dad8", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.199654, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.025985", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.025985", "ticker_sentiment_score": "0.100794", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKXJF", "relevance_score": "0.025985", "ticker_sentiment_score": "0.100794", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSKYF", "relevance_score": "0.025985", "ticker_sentiment_score": "0.100794", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.051943", "ticker_sentiment_score": "0.108756", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.279886", "ticker_sentiment_score": "0.225424", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.025985", "ticker_sentiment_score": "0.100794", "ticker_sentiment_label": "Neutral"}, {"ticker": "IUGNF", "relevance_score": "0.025985", "ticker_sentiment_score": "0.169397", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships - Immix Biopharma  ( NASDAQ:IMMX ) , RenovoRx  ( NASDAQ:RNXT ) ", "url": "https://www.benzinga.com/pressreleases/24/06/g39249080/renovorx-appoints-ryan-witt-as-senior-vice-president-head-of-corporate-strategy-and-partnerships", "time_published": "20240610T123000", "authors": ["Globe Newswire"], "summary": "LOS ALTOS, Calif., June 10, 2024 ( GLOBE NEWSWIRE ) -- RenovoRx, Inc. ( \"RenovoRx\" or the \"Company\" ) RNXT, a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced today that Ryan Witt has joined the Company in ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.197122, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.025139", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.025139", "ticker_sentiment_score": "0.100354", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKXJF", "relevance_score": "0.025139", "ticker_sentiment_score": "0.100354", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSKYF", "relevance_score": "0.025139", "ticker_sentiment_score": "0.100354", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.050254", "ticker_sentiment_score": "0.108579", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.294682", "ticker_sentiment_score": "0.232284", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.025139", "ticker_sentiment_score": "0.100354", "ticker_sentiment_label": "Neutral"}, {"ticker": "IUGNF", "relevance_score": "0.025139", "ticker_sentiment_score": "0.168729", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why MiNK Therapeutics Stock Is Up 11% Monday - MiNK Therapeutics  ( NASDAQ:INKT ) ", "url": "https://www.benzinga.com/news/24/05/38797454/why-mink-therapeutics-stock-is-up-11-monday", "time_published": "20240513T174844", "authors": ["Dylan Berman"], "summary": "MiNK Therapeutics, Inc. INKT shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million. What Happened: On Monday, MiNK Therapeutics entered into a stock purchase agreement to sell securities in a private investment in ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/13/Stock--chart-image-JPG.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.199429, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "INKT", "relevance_score": "0.617765", "ticker_sentiment_score": "0.508723", "ticker_sentiment_label": "Bullish"}, {"ticker": "IMMX", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.053439", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELTX", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.053439", "ticker_sentiment_label": "Neutral"}]}, {"title": "MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer - MiNK Therapeutics  ( NASDAQ:INKT ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g38785308/mink-therapeutics-announces-5-8-million-private-placement-and-appointment-of-board-observer", "time_published": "20240513T113000", "authors": ["Globe Newswire"], "summary": "Financing of $5.8 Million at a 25% premium will help advance the clinical development of MiNK-215, an armored-FAP-CAR-iNKT GKCC, LLC joins as a new investor with Katie Chudnovsky appointed as a Board Observer NEW YORK, May 13, 2024 ( GLOBE NEWSWIRE ) -- MiNK Therapeutics, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.147914, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "INKT", "relevance_score": "0.155451", "ticker_sentiment_score": "0.035384", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.052112", "ticker_sentiment_score": "0.122949", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELTX", "relevance_score": "0.052112", "ticker_sentiment_score": "0.122949", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g38760866/immix-biopharma-announces-positive-nxc-201-relapsedrefractory-al-amyloidosis-clinical-data-in-asgc", "time_published": "20240510T133500", "authors": ["Globe Newswire"], "summary": "92% ( 12/13 ) overall response rate ( ORR ) for relapsed/refractory AL Amyloidosis patients enrolled in NEXICART-1: 12 out of 12 patients not exposed to prior BCMA-targeted bispecific responded to NXC-201 ( 100% ORR ) , of which 9 out of 12 were complete responders ( 75% CRs )", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.073617, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.265089", "ticker_sentiment_score": "-0.004009", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation", "url": "https://www.globenewswire.com/news-release/2024/05/10/2879674/0/en/Immix-Biopharma-Announces-Positive-NXC-201-Relapsed-Refractory-AL-Amyloidosis-Clinical-Data-in-ASGCT-2024-Late-Breaking-Oral-Presentation.html", "time_published": "20240510T133500", "authors": ["Inc.", "Immix Biopharma"], "summary": "92% ( 12/13 ) overall response rate ( ORR ) for relapsed/refractory AL Amyloidosis patients enrolled in ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.047725, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.245615", "ticker_sentiment_score": "-0.003778", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma", "url": "https://www.globenewswire.com/news-release/2024/04/29/2871345/0/en/Immix-Biopharma-Awarded-European-Union-Orphan-Drug-Designation-for-NXC-201-in-Multiple-Myeloma.html", "time_published": "20240429T133900", "authors": ["Immix Biopharma", "Inc."], "summary": "European Orphan Drug Designation ( \"ODD\" ) qualifies NXC-201 for: ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.024105, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.397098", "ticker_sentiment_score": "0.030294", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma on Track to Dose NXC-201 Patients in United States", "url": "https://www.globenewswire.com/news-release/2024/04/18/2865508/0/en/Immix-Biopharma-on-Track-to-Dose-NXC-201-Patients-in-United-States.html", "time_published": "20240418T133200", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022 Scheduling U.S. site initiation visits April and May 2024 \u2022 On track to dose relapsed/refractory AL Amyloidosis patients with CAR-T NXC-201 at New York City lead site and other leading U.S. sites mid-2024", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.083485, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.428632", "ticker_sentiment_score": "0.052202", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy  ( ASGCT ) ", "url": "https://www.globenewswire.com/news-release/2024/04/15/2862875/0/en/Immix-Biopharma-Announces-Late-Breaking-NXC-201-Clinical-Data-Abstract-Accepted-for-Oral-Presentation-at-the-27th-Annual-Meeting-of-the-American-Society-of-Gene-and-Cell-Therapy-AS.html", "time_published": "20240415T133600", "authors": ["Inc.", "Immix Biopharma"], "summary": "LOS ANGELES, April 15, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" or \"IMMX\" ) , a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and other autoimmune diseases, today announced that updated ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.049993, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.281018", "ticker_sentiment_score": "-0.008432", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy  ( ASGCT )  - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/pressreleases/24/04/g38248694/immix-biopharma-announces-late-breaking-nxc-201-clinical-data-abstract-accepted-for-oral-presentat", "time_published": "20240415T133600", "authors": ["Globe Newswire"], "summary": "Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory AL amyloidosis will be presented in Baltimore May 7-11, 2024 LOS ANGELES, April 15, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.061809, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.271274", "ticker_sentiment_score": "-0.008181", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial", "url": "https://www.globenewswire.com/news-release/2024/03/20/2849459/0/en/Immix-Biopharma-Announces-Major-Comprehensive-Cancer-Center-as-Lead-Site-for-NXC-201-AL-Amyloidosis-Clinical-Trial.html", "time_published": "20240320T134600", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, CA, March 20, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" or \"IMMX\" ) , a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and other autoimmune diseases, today announced Memorial Sloan ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.023995, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.389636", "ticker_sentiment_score": "-0.024438", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces \"Be Proactive in AL\" AL Amyloidosis Awareness Initiative", "url": "https://www.globenewswire.com/news-release/2024/03/05/2840587/0/en/Immix-Biopharma-Announces-Be-Proactive-in-AL-AL-Amyloidosis-Awareness-Initiative.html", "time_published": "20240305T143500", "authors": ["Immix Biopharma", "Inc."], "summary": "Hear from the ~30,000 relapsed or refractory AL Amyloidosis patients in the United States today in their own words Hear from the ~30,000 relapsed or refractory AL Amyloidosis patients in the United States today in their own words ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/f478f3fb-ad63-4de9-a38d-49b9701154b1/Immix Biopharma Announces \u201cBe Proactive in AL\u201d AL Amyloidosis Awareness Initiative.png", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.019373, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.38489", "ticker_sentiment_score": "0.069804", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma 12 Month Review Progress Update", "url": "https://www.globenewswire.com/news-release/2024/02/21/2832855/0/en/Immix-Biopharma-12-Month-Review-Progress-Update.html", "time_published": "20240221T143100", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) , a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced its 12-month progress update including shareholder letter.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.139016, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BAC", "relevance_score": "0.040795", "ticker_sentiment_score": "0.145594", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.241085", "ticker_sentiment_score": "0.133816", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.020404", "ticker_sentiment_score": "-0.026128", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.020404", "ticker_sentiment_score": "-0.026128", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Closing of $15 Million Public Offering of Common Stock - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/pressreleases/24/02/g37020480/immix-biopharma-announces-closing-of-15-million-public-offering-of-common-stock", "time_published": "20240208T214500", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, CA, Feb. 08, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" or \"IMMX\" ) , a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, announced today the closing of its previously announced ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.891286"}], "overall_sentiment_score": 0.054343, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.235062", "ticker_sentiment_score": "0.115473", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGPHF", "relevance_score": "0.158", "ticker_sentiment_score": "0.074498", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis", "url": "https://www.globenewswire.com/news-release/2024/02/07/2825304/0/en/Immix-Biopharma-Awarded-European-Union-Orphan-Drug-Designation-for-NXC-201-in-AL-Amyloidosis.html", "time_published": "20240207T143700", "authors": ["Inc.", "Immix Biopharma"], "summary": "European Orphan Drug Designation ( \"ODD\" ) qualifies NXC-201 for: ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.021637, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.203786", "ticker_sentiment_score": "0.075948", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Pricing of $15 Million Public Offering of Common Stock", "url": "https://www.globenewswire.com/news-release/2024/02/06/2823945/0/en/Immix-Biopharma-Announces-Pricing-of-15-Million-Public-Offering-of-Common-Stock.html", "time_published": "20240206T033000", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, CA, Feb. 05, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" or \"IMMX\" ) , a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, today announced that it has priced an underwritten public ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.928769"}], "overall_sentiment_score": 0.087045, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.211806", "ticker_sentiment_score": "0.177575", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PGPHF", "relevance_score": "0.142144", "ticker_sentiment_score": "0.090899", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Pricing of $15 Million Public Offering of Common Stock - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/pressreleases/24/02/g36946949/immix-biopharma-announces-pricing-of-15-million-public-offering-of-common-stock", "time_published": "20240206T033000", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, CA, Feb. 05, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" or \"IMMX\" ) , a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, today announced that it has priced an underwritten public ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.961735"}], "overall_sentiment_score": 0.082264, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.202932", "ticker_sentiment_score": "0.165629", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PGPHF", "relevance_score": "0.136113", "ticker_sentiment_score": "0.08638", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Proposed Public Offering of Common Stock", "url": "https://www.globenewswire.com/news-release/2024/02/05/2823822/0/en/Immix-Biopharma-Announces-Proposed-Public-Offering-of-Common-Stock.html", "time_published": "20240205T202000", "authors": ["Inc.", "Immix Biopharma"], "summary": "LOS ANGELES, Feb. 05, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( the \"Company\" ) , a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced that it intends to offer and sell shares of its common stock in an ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.976913"}], "overall_sentiment_score": 0.070478, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.330876", "ticker_sentiment_score": "0.014284", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGPHF", "relevance_score": "0.135729", "ticker_sentiment_score": "0.082641", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products", "url": "https://markets.businessinsider.com/news/stocks/immix-biopharma-statement-on-january-2024-fda-labeling-change-notification-for-approved-car-t-products-1032992201", "time_published": "20240124T133500", "authors": ["markets.businessinsider.com"], "summary": "LOS ANGELES, CA, Jan. 24, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"Immix Biopharma\", \"Company\", \"We\" or \"Us\", Nasdaq:IMMX ) , a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced a statement on January 2024, FDA labeling change ...", "banner_image": "https://ml.globenewswire.com/media/ODM5MjBmYWItN2EwNi00NGQ5LWFlMGEtZGYxNmQyZDlmZDAzLTUwMDA5ODEwNA==/tiny/Immix-Biopharma-Inc-.png", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.115506, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.56217", "ticker_sentiment_score": "0.165142", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products", "url": "https://www.globenewswire.com/news-release/2024/01/24/2815328/0/en/Immix-Biopharma-Statement-On-January-2024-FDA-Labeling-Change-Notification-For-Approved-CAR-T-Products.html", "time_published": "20240124T133500", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, CA, Jan. 24, 2024 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"Immix Biopharma\", \"Company\", \"We\" or \"Us\", Nasdaq:IMMX ) , a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced a statement on January 2024, FDA labeling change ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.031109, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.237745", "ticker_sentiment_score": "0.096622", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board", "url": "https://www.globenewswire.com/news-release/2024/01/04/2804098/0/en/Immix-Biopharma-Announces-Dr-Vaishali-Sanchorawala-AL-Amyloidosis-Thought-Leader-Director-of-the-Amyloidosis-Center-at-Boston-University-and-Boston-Medical-Center-Joins-Scientific-.html", "time_published": "20240104T143400", "authors": ["Immix Biopharma", "Inc."], "summary": "Dr. Sanchorawala co-authored landmark study of daratumumab ( DARZALEX\u00ae ) in AL Amyloidosis published in The New England Journal of Medicine, 2021 that led to it becoming a first-line standard of care Dr. Sanchorawala co-authored landmark study of daratumumab ( DARZALEX\u00ae ) in AL Amyloidosis ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.136929, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.219809", "ticker_sentiment_score": "0.224787", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Immix Biopharma Announces Dr. Marko Radic, Autoimmune CAR-T Pioneer and Associate Professor at the University of Tennessee Health Science Center, Joins Scientific Advisory Board", "url": "https://www.globenewswire.com/news-release/2023/12/18/2797934/0/en/Immix-Biopharma-Announces-Dr-Marko-Radic-Autoimmune-CAR-T-Pioneer-and-Associate-Professor-at-the-University-of-Tennessee-Health-Science-Center-Joins-Scientific-Advisory-Board.html", "time_published": "20231218T143900", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 Dr. Radic led and authored landmark study demonstrating applicability of CAR-Ts in autoimmune diseases published in Science Translational Medicine, 2019 \u2022 Dr. Radic is a recognized thought leader in autoimmune CAR-T cell therapy, antibody-mediated disorders and designing CAR-T studies", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.054777, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.201244", "ticker_sentiment_score": "0.137351", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces 100% Overall Response Rate  ( n=10 ) ; 23.7 months Best Response Duration  ( ongoing )  for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2023", "url": "https://www.globenewswire.com/news-release/2023/12/11/2793969/0/en/Immix-Biopharma-Announces-100-Overall-Response-Rate-n-10-23-7-months-Best-Response-Duration-ongoing-for-CAR-T-NXC-201-in-Relapsed-Refractory-AL-Amyloidosis-Patients-at-ASH-2023.html", "time_published": "20231211T143600", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 100% ( 10/10 ) overall response rate ( ORR ) and 70% ( 7/10 ) complete response ( CR ) rate observed in standard of care ( Dara-CyBorD ) relapsed/refractory AL Amyloidosis patients with median 6 lines of prior therapy in updated Phase 1/2 data as of December 10, 2023 \u2022 Best responder duration ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/ad6ef384-8fb0-40c5-8332-15d4038f737e", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.066411, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.181477", "ticker_sentiment_score": "0.03124", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit", "url": "https://www.globenewswire.com/news-release/2023/11/30/2788706/0/en/Immix-Biopharma-to-Present-at-the-2023-JMP-Securities-Hematology-and-Oncology-Summit.html", "time_published": "20231130T144600", "authors": ["Inc.", "Immix Biopharma"], "summary": "LOS ANGELES, Nov. 30, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, today announced that it will present and host institutional ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.033387, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.197413", "ticker_sentiment_score": "0.093181", "ticker_sentiment_label": "Neutral"}]}, {"title": "What Makes Immix Biopharma, Inc.  ( IMMX )  a Good Fit for 'Trend Investing'", "url": "https://www.zacks.com/stock/news/2190215/what-makes-immix-biopharma-inc-immx-a-good-fit-for-trend-investing", "time_published": "20231128T135005", "authors": ["Zacks Equity Research"], "summary": "Immix Biopharma, Inc. (IMMX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default3.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99793"}], "overall_sentiment_score": 0.362007, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.423843", "ticker_sentiment_score": "0.436424", "ticker_sentiment_label": "Bullish"}]}, {"title": "Immix  ( IMMX )  CAR-T Therapy IND Cleared by FDA, Stock Down", "url": "https://www.zacks.com/stock/news/2187964/immix-immx-car-t-therapy-ind-cleared-by-fda-stock-down", "time_published": "20231122T161000", "authors": ["Zacks Equity Research"], "summary": "The FDA clears Immix's (IMMX) investigational new drug application for BCMA CAR-T cell therapy, NXC-201, to expand clinical studies in relapsed/refractory AL amyloidosis to the United States. Stock falls.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default199.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998626"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.098225, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LGND", "relevance_score": "0.401331", "ticker_sentiment_score": "0.301134", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.401331", "ticker_sentiment_score": "0.052647", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.139265", "ticker_sentiment_score": "0.054537", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.339046", "ticker_sentiment_score": "0.174543", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted CAR-T Cell Therapy Candidate NXC-201 for Relapsed/Refractory AL Amyloidosis", "url": "https://www.globenewswire.com/news-release/2023/11/22/2784854/0/en/Immix-Biopharma-to-Host-KOL-Event-to-Discuss-its-BCMA-Targeted-CAR-T-Cell-Therapy-Candidate-NXC-201-for-Relapsed-Refractory-AL-Amyloidosis.html", "time_published": "20231122T141900", "authors": ["Immix Biopharma", "Inc."], "summary": "Virtual Event to be held on November 29, 2023 at 4:15 p.m. ET Virtual Event to be held on November 29, 2023 at 4:15 p.m. ET ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.068565, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.084796", "ticker_sentiment_score": "0.043358", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing", "url": "https://www.globenewswire.com/news-release/2023/11/21/2784152/0/en/Immix-Biopharma-Announces-FDA-Approval-of-IND-Application-for-CAR-T-NXC-201-Enabling-U-S-Patient-Dosing.html", "time_published": "20231121T144600", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, Nov. 21, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq:IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a clinical-stage biopharmaceutical company advancing personalized therapies for oncology and immunology, today announced that the U.S.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.077985, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.143273", "ticker_sentiment_score": "0.114492", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing", "url": "https://www.globenewswire.com/news-release/2023/11/21/2784154/0/en/Immix-Biopharma-Announces-FDA-Approval-of-IND-Application-for-CAR-T-NXC-201-Enabling-U-S-Patient-Dosing.html", "time_published": "20231121T144600", "authors": ["Inc.", "Immix Biopharma"], "summary": "LOS ANGELES, Nov. 21, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq:IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a clinical-stage biopharmaceutical company advancing personalized therapies for oncology and immunology, today announced that the U.S.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.077987, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.143273", "ticker_sentiment_score": "0.114497", "ticker_sentiment_label": "Neutral"}]}, {"title": "CFO at Immix Biopharma Acquires Company Stock Options Worth 293,000 Shares - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/news/23/11/35726437/cfo-at-immix-biopharma-acquires-company-stock-options-worth-293-000-shares", "time_published": "20231110T150022", "authors": ["Benzinga Insights"], "summary": "Gabriel Morris, CFO at Immix Biopharma IMMX, reported a large acquisition of company stock options on November 10, according to a new SEC filing. What Happened: A Form 4 filing from the U.S.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/insider_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99676"}], "overall_sentiment_score": 0.245827, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.522854", "ticker_sentiment_score": "0.550224", "ticker_sentiment_label": "Bullish"}]}, {"title": "Immix Biopharma Presents NXC-201 Data at 65th American Society of Hematology  ( ASH )  Annual Meeting in 9 Relapsed/Refractory AL Amyloidosis Patients", "url": "https://www.globenewswire.com/news-release/2023/11/06/2774208/0/en/Immix-Biopharma-Presents-NXC-201-Data-at-65th-American-Society-of-Hematology-ASH-Annual-Meeting-in-9-Relapsed-Refractory-AL-Amyloidosis-Patients.html", "time_published": "20231106T141200", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022 100% overall response rate observed in relapsed/refractory AL Amyloidosis patients with median 6 lines of prior therapy \u2022 Updated results will be communicated at the presentation time December 10, 2023", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.05682, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.162437", "ticker_sentiment_score": "0.046682", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Presents NXC-201 Data at 65th American Society of Hematology  ( ASH )  Annual Meeting in 63 Relapsed/Refractory Multiple Myeloma Patients", "url": "https://www.globenewswire.com/news-release/2023/11/06/2774141/0/en/Immix-Biopharma-Presents-NXC-201-Data-at-65th-American-Society-of-Hematology-ASH-Annual-Meeting-in-63-Relapsed-Refractory-Multiple-Myeloma-Patients.html", "time_published": "20231106T134000", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 95% overall response rate observed in relapsed/refractory multiple myeloma patients not previously treated with BCMA-targeted therapy \u2022 98% overall response rate observed in relapsed/refractory multiple myeloma patients without extra-medullary disease \u2022 Updated results will be communicated at ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.045106, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.187775", "ticker_sentiment_score": "0.072451", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why Immix Biopharma, Inc.  ( IMMX )  Is a Great 'Buy the Bottom' Stock Now", "url": "https://www.zacks.com/stock/news/2175454/heres-why-immix-biopharma-inc-immx-is-a-great-buy-the-bottom-stock-now", "time_published": "20231031T135506", "authors": ["Zacks Equity Research"], "summary": "Immix Biopharma, Inc. (IMMX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default11.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.187283, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.414559", "ticker_sentiment_score": "0.397989", "ticker_sentiment_label": "Bullish"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Announces Dr. Michaela Liedtke, Stanford Medicine Cancer Center Hematology Program Lead and Co-Director Stanford Amyloid Center, Joins Scientific Advisory Board", "url": "https://www.globenewswire.com/news-release/2023/10/26/2767568/0/en/Immix-Biopharma-Subsidiary-Nexcella-Announces-Dr-Michaela-Liedtke-Stanford-Medicine-Cancer-Center-Hematology-Program-Lead-and-Co-Director-Stanford-Amyloid-Center-Joins-Scientific-A.html", "time_published": "20231026T125800", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , announced that effective today, Dr. Michaela Liedtke has joined ImmixBio subsidiary Nexcella Scientific Advisory Board.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.104466, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.187705", "ticker_sentiment_score": "0.153743", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Immix Biopharma Completes 3rd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site", "url": "https://www.globenewswire.com/news-release/2023/10/16/2760736/0/en/Immix-Biopharma-Completes-3rd-NXC-201-Engineering-Batch-at-its-U-S-CAR-T-Manufacturing-Site.html", "time_published": "20231016T130500", "authors": ["Inc.", "Immix Biopharma"], "summary": "LOS ANGELES, Oct. 16, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) today announced the successful completion of its 3rd engineering batch of BCMA-targeted chimeric antigen receptor T ( CAR-T ) cell therapy NXC-201 at its U.S. manufacturing site.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.094771, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.212425", "ticker_sentiment_score": "0.110812", "ticker_sentiment_label": "Neutral"}]}, {"title": "New CAR-T Therapy Shows Potency in Certain Patients", "url": "https://www.investorideas.com/news/2023/biotech/10052CAR-T-Therapy.asp", "time_published": "20231005T163253", "authors": [], "summary": "October 5, 2023 ( Investorideas.com Newswire ) Study results for patients with relapsed/refractory multiple myeloma continue to be \"favorable,\" noted a ROTH Capital Partners report.", "banner_image": "https://www.streetwisereports.com/images/national-cancer-institute-GcrSgHDrniY-unsplash_2.jpg", "source": "Investor Ideas", "category_within_source": "n/a", "source_domain": "www.investorideas.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.121439, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.047844", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Complete Response in 9th Relapsed/Refractory AL Amyloidosis Patient in NXC-201 Clinical Trial at IMS 20th Annual Meeting", "url": "https://www.globenewswire.com/news-release/2023/10/03/2753760/0/en/Immix-Biopharma-Announces-Complete-Response-in-9th-Relapsed-Refractory-AL-Amyloidosis-Patient-in-NXC-201-Clinical-Trial-at-IMS-20th-Annual-Meeting.html", "time_published": "20231003T131400", "authors": ["Inc.", "Immix Biopharma"], "summary": "LOS ANGELES, Oct. 03, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , today announced presentation of additional AL Amyloidosis clinical data from its Phase 1b/2a NEXICART-1 ( NCT04720313 ) study of novel, autologous, BCMA-targeted chimeric antigen ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/1f1a1257-c9f2-4d9c-9e24-bdb859f3ca22", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.066199, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.152775", "ticker_sentiment_score": "0.05947", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's Going On With Cancer-Focused Immix Biopharma Stock Today? - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/general/biotech/23/10/35036704/whats-going-on-with-cancer-focused-immix-biopharma-stock-today", "time_published": "20231002T182520", "authors": ["Vandana Singh"], "summary": "Immix Biopharma Inc IMMX announced the presentation of updated data from the ongoing Phase 1b/2 NEXICART-1 study of its NXC-201, an autologous, BCMA-targeted chimeric antigen receptor T ( CAR-T ) cell therapy. The updated dataset consists of 63 multiple myeloma patients.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/02/immx.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.237334, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.543004", "ticker_sentiment_score": "0.159096", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Immix Biopharma Announces 72-Patient NXC-201 Clinical Data at the IMS 20th Annual Meeting, 95% Overall Response Rate in Multiple Myeloma", "url": "https://www.globenewswire.com/news-release/2023/10/02/2752722/0/en/Immix-Biopharma-Announces-72-Patient-NXC-201-Clinical-Data-at-the-IMS-20th-Annual-Meeting-95-Overall-Response-Rate-in-Multiple-Myeloma.html", "time_published": "20231002T120600", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022 95% overall response rate observed in relapsed/refractory multiple myeloma patients not previously treated with BCMA-targeted therapy.", "banner_image": "https://ml.globenewswire.com/Resource/Download/f54fb6fb-4a26-44a1-b685-e1330d988de1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.094346, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.178167", "ticker_sentiment_score": "0.04093", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix  ( IMMX )  Up on Orphan Drug Tag for AL Amyloidosis Therapy", "url": "https://www.zacks.com/stock/news/2154401/immix-immx-up-on-orphan-drug-tag-for-al-amyloidosis-therapy", "time_published": "20230922T160400", "authors": ["Zacks Equity Research"], "summary": "Immix (IMMX) gets ODD designation in the United States for lead candidate NXC-201 for the treatment of amyloid light chain (AL) Amyloidosis.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ba/1149.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.137301, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DVAX", "relevance_score": "0.176502", "ticker_sentiment_score": "0.102887", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.262052", "ticker_sentiment_score": "-0.091859", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETON", "relevance_score": "0.176502", "ticker_sentiment_score": "0.102887", "ticker_sentiment_label": "Neutral"}]}, {"title": "U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Amyloid Light Chain  ( AL )  Amyloidosis", "url": "https://www.globenewswire.com/news-release/2023/09/21/2747310/0/en/U-S-Food-and-Drug-Administration-Approves-Orphan-Drug-Designation-for-Immix-Biopharma-NXC-201-as-a-Treatment-for-Amyloid-Light-Chain-AL-Amyloidosis.html", "time_published": "20230921T125500", "authors": ["Immix Biopharma", "Inc."], "summary": "FDA Orphan Drug Designation ( \"ODD\" ) qualifies one-time treatment NXC-201 for: ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.069122, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.219667", "ticker_sentiment_score": "0.084124", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Completes 2nd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site", "url": "https://www.globenewswire.com/news-release/2023/09/19/2745730/0/en/Immix-Biopharma-Subsidiary-Nexcella-Completes-2nd-NXC-201-Engineering-Batch-at-its-U-S-CAR-T-Manufacturing-Site.html", "time_published": "20230919T131000", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022 Successful completion supports expansion of its ongoing NEXICART-1 ( NCT04720313 ) NXC-201 CAR-T clinical trial to the U.S. \u2022 Plan for NXC-201 to expand into earlier lines of therapy, and beyond the 5% of U.S. hospitals that offer CAR-T today", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.080287, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.218161", "ticker_sentiment_score": "0.12518", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nexcella, Immix Biopharma Subsidiary, to Present at the Bank of America 2023 Healthcare Trailblazers Private Company Conference", "url": "https://www.globenewswire.com/news-release/2023/09/07/2739384/0/en/Nexcella-Immix-Biopharma-Subsidiary-to-Present-at-the-Bank-of-America-2023-Healthcare-Trailblazers-Private-Company-Conference.html", "time_published": "20230907T124100", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, Sept. 07, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, today announced that Nexcella NXC-201 clinical data will be ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.052138, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.2741", "ticker_sentiment_score": "0.132921", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board", "url": "https://www.globenewswire.com/news-release/2023/09/01/2736017/0/en/Immix-Biopharma-Announces-Dr-Suzanne-Lentzsch-Director-of-the-Multiple-Myeloma-and-Amyloidosis-Program-at-the-College-of-Physicians-and-Surgeons-of-Columbia-University-and-at-New-Y.html", "time_published": "20230901T123900", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, Sept. 01, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, announced that effective today, Dr. Suzanne Lentzsch has joined the Nexcella ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.051957, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.087397", "ticker_sentiment_score": "0.002073", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.173749", "ticker_sentiment_score": "0.080542", "ticker_sentiment_label": "Neutral"}]}, {"title": "U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Multiple Myeloma", "url": "https://www.globenewswire.com/news-release/2023/08/23/2730428/0/en/U-S-Food-and-Drug-Administration-Approves-Orphan-Drug-Designation-for-Immix-Biopharma-NXC-201-as-a-Treatment-for-Multiple-Myeloma.html", "time_published": "20230823T123700", "authors": ["Immix Biopharma", "Inc."], "summary": "FDA Orphan Drug Designation ( \"ODD\" ) qualifies NXC-201 for: ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.012051, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.193465", "ticker_sentiment_score": "0.006388", "ticker_sentiment_label": "Neutral"}]}, {"title": "U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Multiple Myeloma - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/pressreleases/23/08/g34002586/u-s-food-and-drug-administration-approves-orphan-drug-designation-for-immix-biopharma-nxc-201-as-a", "time_published": "20230823T123700", "authors": ["Globe Newswire"], "summary": "FDA Orphan Drug Designation ( \"ODD\" ) qualifies NXC-201 for: 7 years of U.S. market exclusivity after approval Tax credits for qualified clinical testing Waiver of the Prescription Drug User Fee ( currently at almost $3 million for a new drug )", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.009645, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.19117", "ticker_sentiment_score": "0.007879", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Dr. Heather Landau, Memorial Sloan Kettering Cancer Center Amyloidosis Program Director, Joins Nexcella Scientific Advisory Board", "url": "https://www.globenewswire.com/news-release/2023/08/18/2728014/0/en/Immix-Biopharma-Announces-Dr-Heather-Landau-Memorial-Sloan-Kettering-Cancer-Center-Amyloidosis-Program-Director-Joins-Nexcella-Scientific-Advisory-Board.html", "time_published": "20230818T132000", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, Aug. 18, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"Immix Biopharma\", \"Company\", \"We\" or \"Us\" ) ( Nasdaq:IMMX ) , a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, announced that Dr. Heather Landau has joined the ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.078264, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.235823", "ticker_sentiment_score": "0.166606", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Immix Biopharma Announces Additional NXC-201 AL Amyloidosis Clinical Data Accepted for Oral Presentation at the 20th International Myeloma Society Annual Meeting  ( September 27-30, Athens Greece ) ", "url": "https://www.globenewswire.com/news-release/2023/08/16/2726453/0/en/Immix-Biopharma-Announces-Additional-NXC-201-AL-Amyloidosis-Clinical-Data-Accepted-for-Oral-Presentation-at-the-20th-International-Myeloma-Society-Annual-Meeting-September-27-30-At.html", "time_published": "20230816T130500", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, Aug. 16, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, today announced that additional NXC-201 clinical data for relapsed/refractory ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.073048, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.121804", "ticker_sentiment_score": "0.075051", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Announces NXC-201 Multiple Myeloma Clinical Data Abstract Accepted for Presentation at the 20th International Myeloma Society Annual Meeting", "url": "https://www.globenewswire.com/news-release/2023/07/25/2710456/0/en/Immix-Biopharma-Subsidiary-Nexcella-Announces-NXC-201-Multiple-Myeloma-Clinical-Data-Abstract-Accepted-for-Presentation-at-the-20th-International-Myeloma-Society-Annual-Meeting.html", "time_published": "20230725T124200", "authors": ["Inc.", "Immix Biopharma"], "summary": "Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in Athens September 27-30, 2023 Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in Athens September ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.080241, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.15769", "ticker_sentiment_score": "0.029487", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Reports 2nd Positive Interim Clinical Trial Data Readout in Relapsed/Refractory Metastatic Colorectal Cancer in Ongoing Phase 1b/2a IMX-110 IMMINENT-01 Clinical Trial", "url": "https://www.globenewswire.com/news-release/2023/07/17/2705723/0/en/Immix-Biopharma-Reports-2nd-Positive-Interim-Clinical-Trial-Data-Readout-in-Relapsed-Refractory-Metastatic-Colorectal-Cancer-in-Ongoing-Phase-1b-2a-IMX-110-IMMINENT-01-Clinical-Tri.html", "time_published": "20230717T133700", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 Tumor shrinkage was observed in 3 out of 4 ( 75% ) patients. 1 out of 4 ( 25% ) experienced tumor control as of the July 7, 2023 clinical data cutoff date.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.00725, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.186327", "ticker_sentiment_score": "0.01379", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.02686", "ticker_sentiment_score": "0.013315", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.053689", "ticker_sentiment_score": "0.019013", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Completes Initial NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site", "url": "https://www.globenewswire.com/news-release/2023/07/10/2701885/0/en/Immix-Biopharma-Subsidiary-Nexcella-Completes-Initial-NXC-201-Engineering-Batch-at-its-U-S-CAR-T-Manufacturing-Site.html", "time_published": "20230710T134700", "authors": ["Inc.", "Immix Biopharma"], "summary": "Supports planned expansion of its ongoing NEXICART-1 ( NCT04720313 ) NXC-201 CAR-T clinical trial to the U.S. Supports planned expansion of its ongoing NEXICART-1 ( NCT04720313 ) NXC-201 CAR-T clinical trial to the U.S.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.042615, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.208689", "ticker_sentiment_score": "0.031183", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.026386", "ticker_sentiment_score": "-0.039658", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Completes Pre-IND Meeting with FDA on NXC-201 US Clinical Trial", "url": "https://www.globenewswire.com/news-release/2023/06/26/2694561/0/en/Immix-Biopharma-Subsidiary-Nexcella-Completes-Pre-IND-Meeting-with-FDA-on-NXC-201-US-Clinical-Trial.html", "time_published": "20230626T134900", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, June 26, 2023 ( GLOBE NEWSWIRE ) -- Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. ( \"Nexcella\", \"Company\", \"We\" or \"Us\" ) , a biopharmaceutical company pioneering cell therapies targeting oncology and other diseases, today announced it has completed a Pre-Investigational New ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.123877, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.195814", "ticker_sentiment_score": "0.035996", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Appoints Edward J. Borkowski, former Chief Financial Officer of Mylan N.V, to Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/06/22/2693043/0/en/Immix-Biopharma-Subsidiary-Nexcella-Appoints-Edward-J-Borkowski-former-Chief-Financial-Officer-of-Mylan-N-V-to-Board-of-Directors.html", "time_published": "20230622T135300", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022 Mr. Borkowski joins the Nexcella, Inc. Board of Directors with more than 30 years of experience in the pharmaceutical and healthcare industry, including 7 years as Chief Financial Officer of Mylan N.V. \u2022 Mr. Borkowski is also the former Chief Financial Officer of CareFusion, which was ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.112677, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.243237", "ticker_sentiment_score": "0.088893", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.035293", "ticker_sentiment_score": "0.048254", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNVVF", "relevance_score": "0.035293", "ticker_sentiment_score": "0.048254", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Appoints Jeffrey H. Cooper, former Chief Financial Officer of BioMarin, to Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/06/20/2691253/0/en/Immix-Biopharma-Subsidiary-Nexcella-Appoints-Jeffrey-H-Cooper-former-Chief-Financial-Officer-of-BioMarin-to-Board-of-Directors.html", "time_published": "20230620T134500", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022 Mr. Cooper joins the Nexcella, Inc.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.266143"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.077674, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BMRN", "relevance_score": "0.073773", "ticker_sentiment_score": "0.041279", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.254118", "ticker_sentiment_score": "0.082396", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.073773", "ticker_sentiment_score": "-0.024154", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Appoints Mary Sue Coleman, former Johnson & Johnson Independent Director, to Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/06/16/2689773/0/en/Immix-Biopharma-Subsidiary-Nexcella-Appoints-Mary-Sue-Coleman-former-Johnson-Johnson-Independent-Director-to-Board-of-Directors.html", "time_published": "20230616T134300", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 Dr. Coleman joins the Nexcella, Inc. Board of Directors with over a decade of experience as an Independent Director of Johnson & Johnson from 2003-2016 \u2022 Dr. Coleman is President Emerita of the University of Michigan where she was named one of \"10 Best College Presidents\" by TIME Magazine and ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.167944, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.160811", "ticker_sentiment_score": "0.060931", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.107615", "ticker_sentiment_score": "0.107901", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Completes $5 Million At-The-Market Equity Offering Program - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/pressreleases/23/06/g32852120/immix-biopharma-completes-5-million-at-the-market-equity-offering-program", "time_published": "20230614T113000", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, June 14, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc., IMMX ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a biopharmaceutical company pioneering CAR-T cell therapies and tissue specific therapeutics targeting oncology and immuno-dysregulated diseases, today announced that it has ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980716"}], "overall_sentiment_score": 0.066227, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.281692", "ticker_sentiment_score": "0.060763", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Completes $5 Million At-The-Market Equity Offering Program", "url": "https://www.globenewswire.com/news-release/2023/06/14/2687971/0/en/Immix-Biopharma-Completes-5-Million-At-The-Market-Equity-Offering-Program.html", "time_published": "20230614T113000", "authors": ["Inc.", "Immix Biopharma"], "summary": "Participating institutional investors include Bridgewest Group Participating institutional investors include Bridgewest Group ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.961735"}], "overall_sentiment_score": 0.068652, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.240014", "ticker_sentiment_score": "0.055292", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Appoints Henry McKinnell, Jr., former Chairman & CEO of Pfizer Inc., to Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/06/12/2686410/0/en/Immix-Biopharma-Subsidiary-Nexcella-Appoints-Henry-McKinnell-Jr-former-Chairman-CEO-of-Pfizer-Inc-to-Board-of-Directors.html", "time_published": "20230612T134900", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 Dr. McKinnell joins the Nexcella, Inc. Board of Directors with 35 years of experience at Pfizer, Inc., including 6 years as Chairman and Chief Executive Officer \u2022 Dr. McKinnell is a former independent director of ChemoCentryx, acquired by Amgen for $3.7 billion in 2022 and former Chairman/CEO ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.113028, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MCO", "relevance_score": "0.035241", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TM", "relevance_score": "0.035241", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGTI", "relevance_score": "0.035241", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.209064", "ticker_sentiment_score": "0.08082", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.14028", "ticker_sentiment_score": "0.025497", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.035241", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella Announces Commencement of NXC-201 Engineering Batches at its U.S. CAR-T Manufacturing Site", "url": "https://www.globenewswire.com/news-release/2023/05/26/2677180/0/en/Immix-Biopharma-Subsidiary-Nexcella-Announces-Commencement-of-NXC-201-Engineering-Batches-at-its-U-S-CAR-T-Manufacturing-Site.html", "time_published": "20230526T135300", "authors": ["Immix Biopharma", "Inc."], "summary": "\u2022 U.S. engineering batches support planned expansion of its ongoing NEXICART-1 ( NCT04720313 ) NXC-201 CAR-T clinical trial to the United States \u2022 Engineering batches are the first step in transferring the Company's existing CAR-T GMP manufacturing process to the United States \u2022 Commencement of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.061707, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.181721", "ticker_sentiment_score": "0.032747", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.026184", "ticker_sentiment_score": "-0.051498", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Absci  ( NASDAQ:ABSI ) , ADS-TEC Energy  ( NASDAQ:ADSE ) ", "url": "https://www.benzinga.com/news/23/05/32513895/why-zim-integrated-shipping-services-shares-are-trading-lower-by-14-here-are-other-stocks-moving-in", "time_published": "20230522T172039", "authors": ["Lisa Levin"], "summary": "Greenhill & Co., Inc. GHL shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. AVROBIO, Inc. AVRO gained 93.5% to $1.50 after the company announced it would sell its gene therapy program to Novartis for $87.5 million. Microbot Medical Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/22/zim_integrated_shipping_services_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.917436"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.121692, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AVIR", "relevance_score": "0.1145", "ticker_sentiment_score": "0.228926", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BHG", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTLK", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGC", "relevance_score": "0.1145", "ticker_sentiment_score": "-0.27836", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BJDX", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BXRX", "relevance_score": "0.1145", "ticker_sentiment_score": "-0.179505", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BIOC", "relevance_score": "0.1145", "ticker_sentiment_score": "0.014114", "ticker_sentiment_label": "Neutral"}, {"ticker": "COCO", "relevance_score": "0.076479", "ticker_sentiment_score": "0.008214", "ticker_sentiment_label": "Neutral"}, {"ticker": "VECT", "relevance_score": "0.076479", "ticker_sentiment_score": "0.116382", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLCN", "relevance_score": "0.076479", "ticker_sentiment_score": "-0.032962", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHL", "relevance_score": "0.076479", "ticker_sentiment_score": "0.209004", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HEPA", "relevance_score": "0.076479", "ticker_sentiment_score": "0.298965", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RXT", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAVD", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRWD", "relevance_score": "0.038284", "ticker_sentiment_score": "0.111127", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCPL", "relevance_score": "0.076479", "ticker_sentiment_score": "0.440492", "ticker_sentiment_label": "Bullish"}, {"ticker": "CNSP", "relevance_score": "0.1145", "ticker_sentiment_score": "0.136088", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBTX", "relevance_score": "0.1145", "ticker_sentiment_score": "0.212068", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MBOT", "relevance_score": "0.076479", "ticker_sentiment_score": "0.264168", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SFR", "relevance_score": "0.1145", "ticker_sentiment_score": "0.122314", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZVSA", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.1145", "ticker_sentiment_score": "0.157046", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TRNR", "relevance_score": "0.076479", "ticker_sentiment_score": "-0.382005", "ticker_sentiment_label": "Bearish"}, {"ticker": "MU", "relevance_score": "0.076479", "ticker_sentiment_score": "-0.034031", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNMV", "relevance_score": "0.038284", "ticker_sentiment_score": "0.058521", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADSE", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.076479", "ticker_sentiment_score": "0.111306", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.076479", "ticker_sentiment_score": "0.06164", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.076479", "ticker_sentiment_score": "-0.382005", "ticker_sentiment_label": "Bearish"}, {"ticker": "SQL", "relevance_score": "0.1145", "ticker_sentiment_score": "-0.005829", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBRG", "relevance_score": "0.038284", "ticker_sentiment_score": "-0.174244", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MGRM", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.076479", "ticker_sentiment_score": "0.190648", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CELU", "relevance_score": "0.1145", "ticker_sentiment_score": "0.10554", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVB", "relevance_score": "0.1145", "ticker_sentiment_score": "0.023955", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIO", "relevance_score": "0.076479", "ticker_sentiment_score": "0.290773", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QBTS", "relevance_score": "0.1145", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.076479", "ticker_sentiment_score": "-0.025734", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRSO", "relevance_score": "0.1145", "ticker_sentiment_score": "0.054996", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICPT", "relevance_score": "0.1145", "ticker_sentiment_score": "0.029579", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGTX", "relevance_score": "0.076479", "ticker_sentiment_score": "-0.282584", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRCT", "relevance_score": "0.1145", "ticker_sentiment_score": "0.089306", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXR", "relevance_score": "0.076479", "ticker_sentiment_score": "0.116382", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIM", "relevance_score": "0.076479", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/general/biotech/23/05/32508031/immix-biopharmas-subsidiary-says-investigational-car-t-therapy-shows-100-response-rate-in-amyloid", "time_published": "20230522T154819", "authors": ["Vandana Singh"], "summary": "Immix Biopharma Inc's IMMX subsidiary Nexcella Inc announced updated AL Amyloidosis clinical data from its ongoing Phase 1b/2a NEXICART-1 study of its BCMA-targeted chimeric antigen receptor T ( CAR-T ) cell therapy NXC-201 for relapsed or refractory multiple myeloma and light chain ( AL ) ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/22/immx.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.120352, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.524949", "ticker_sentiment_score": "0.202802", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BGNE", "relevance_score": "0.279015", "ticker_sentiment_score": "0.236262", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket - Baudax Bio  ( NASDAQ:BXRX ) , Biocept  ( NASDAQ:BIOC ) ", "url": "https://www.benzinga.com/news/23/05/32505849/why-immix-biopharma-shares-are-trading-higher-by-around-45-here-are-20-stocks-moving-premarket", "time_published": "20230522T120658", "authors": ["Lisa Levin"], "summary": "SeqLL Inc. SQL shares surged 61.1% to $0.54 in pre-market trading after dropping 14% on Friday. SeqLL recently posted a wider first-quarter loss. CNS Pharmaceuticals, Inc. CNSP shares rose 45.3% to $2.31 in pre-market trading after gaining around 18% on Friday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/22/immix_biopharma_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.094135, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ZVSA", "relevance_score": "0.159569", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGC", "relevance_score": "0.237358", "ticker_sentiment_score": "-0.37693", "ticker_sentiment_label": "Bearish"}, {"ticker": "BXRX", "relevance_score": "0.237358", "ticker_sentiment_score": "-0.246894", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BIOC", "relevance_score": "0.237358", "ticker_sentiment_score": "0.018865", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLCN", "relevance_score": "0.159569", "ticker_sentiment_score": "0.084562", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.159569", "ticker_sentiment_score": "0.168928", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IMMX", "relevance_score": "0.159569", "ticker_sentiment_score": "0.34046", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDNA", "relevance_score": "0.159569", "ticker_sentiment_score": "-0.358414", "ticker_sentiment_label": "Bearish"}, {"ticker": "ZAPP", "relevance_score": "0.159569", "ticker_sentiment_score": "-0.359692", "ticker_sentiment_label": "Bearish"}, {"ticker": "HEPA", "relevance_score": "0.237358", "ticker_sentiment_score": "0.136126", "ticker_sentiment_label": "Neutral"}, {"ticker": "IZEA", "relevance_score": "0.237358", "ticker_sentiment_score": "-0.217861", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SQL", "relevance_score": "0.237358", "ticker_sentiment_score": "-0.007496", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBRG", "relevance_score": "0.080188", "ticker_sentiment_score": "-0.191768", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CELU", "relevance_score": "0.237358", "ticker_sentiment_score": "0.148468", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCPL", "relevance_score": "0.159569", "ticker_sentiment_score": "0.478157", "ticker_sentiment_label": "Bullish"}, {"ticker": "CNSP", "relevance_score": "0.237358", "ticker_sentiment_score": "0.192676", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NBTX", "relevance_score": "0.237358", "ticker_sentiment_score": "0.300774", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DXR", "relevance_score": "0.159569", "ticker_sentiment_score": "0.220453", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TORO", "relevance_score": "0.159569", "ticker_sentiment_score": "0.225724", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Immix Biopharma Announces Positive NXC-201 Clinical Results at ASGCT: 100% Overall Response Rate in DARZALEX-Relapsed/Refractory AL Amyloidosis with Zero ICANs in Ongoing NEXICART-1 Phase 1b/2a Clinical Trial", "url": "https://www.globenewswire.com/news-release/2023/05/21/2672908/0/en/Immix-Biopharma-Announces-Positive-NXC-201-Clinical-Results-at-ASGCT-100-Overall-Response-Rate-in-DARZALEX-Relapsed-Refractory-AL-Amyloidosis-with-Zero-ICANs-in-Ongoing-NEXICART-1-.html", "time_published": "20230521T200000", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, May 21, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , today announced updated AL Amyloidosis clinical data from its ongoing Phase 1b/2a NEXICART-1 ( NCT04720313 ) study of its novel, autologous, BCMA-targeted chimeric antigen receptor T ( ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.126638, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.144275", "ticker_sentiment_score": "0.030545", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 26th Annual Meeting of The American Society of Gene and Cell Therapy  ( ASGCT ) ", "url": "https://www.globenewswire.com/news-release/2023/05/04/2661902/0/en/Immix-Biopharma-Announces-Late-Breaking-NXC-201-Clinical-Data-Abstract-Accepted-for-Oral-Presentation-at-the-26th-Annual-Meeting-of-The-American-Society-of-Gene-and-Cell-Therapy-AS.html", "time_published": "20230504T163000", "authors": ["Inc.", "Immix Biopharma"], "summary": "\u2022Updated clinical data for next-generation CAR-T NXC-201 in AL amyloidosis will be presented in Los Angeles May 16-20, 2023 \u2022Updated clinical data for next-generation CAR-T NXC-201 in AL amyloidosis will be presented in Los Angeles May ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.049851, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.225425", "ticker_sentiment_score": "0.043658", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.028558", "ticker_sentiment_score": "0.027725", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's Going On With Immix Biopharma  ( IMMX )  Stock Today - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/general/biotech/23/05/32191738/whats-going-on-with-immix-biopharma-stock-today", "time_published": "20230503T184211", "authors": ["Vandana Singh"], "summary": "Immix Biopharma Inc IMMX announced early interim data from IMMINENT-01 Phase 1b/2a trial combining tissue-specific therapeutic IMX-110 with BeiGene Ltd BGNE / Novartis AG's NVS tislelizumab, for advanced solid tumors.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/03/aapharma_8.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.128561, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.612033", "ticker_sentiment_score": "0.48729", "ticker_sentiment_label": "Bullish"}, {"ticker": "BGNE", "relevance_score": "0.334008", "ticker_sentiment_score": "0.297389", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - American Rebel Holdings  ( NASDAQ:AREB ) , Atomera  ( NASDAQ:ATOM ) ", "url": "https://www.benzinga.com/news/23/04/32043114/why-meta-platforms-shares-are-trading-higher-by-over-11-here-are-20-stocks-moving-premarket", "time_published": "20230427T114104", "authors": ["Lisa Levin"], "summary": "Evelo Biosciences, Inc. EVLO gained 115.4% to $0.2154 in pre-market trading. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/27/facebook_-_logo.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.82617"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.048232, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.139669", "ticker_sentiment_score": "0.445039", "ticker_sentiment_label": "Bullish"}, {"ticker": "BXRX", "relevance_score": "0.139669", "ticker_sentiment_score": "-0.166003", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INAB", "relevance_score": "0.208166", "ticker_sentiment_score": "-0.15457", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MGRX", "relevance_score": "0.208166", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGIO", "relevance_score": "0.139669", "ticker_sentiment_score": "0.299315", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IDEX", "relevance_score": "0.139669", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.208166", "ticker_sentiment_score": "0.399593", "ticker_sentiment_label": "Bullish"}, {"ticker": "OPGN", "relevance_score": "0.139669", "ticker_sentiment_score": "0.18686", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STM", "relevance_score": "0.070105", "ticker_sentiment_score": "0.063654", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOM", "relevance_score": "0.139669", "ticker_sentiment_score": "0.078842", "ticker_sentiment_label": "Neutral"}, {"ticker": "AREB", "relevance_score": "0.139669", "ticker_sentiment_score": "0.126955", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.208166", "ticker_sentiment_score": "-0.176815", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EVLO", "relevance_score": "0.208166", "ticker_sentiment_score": "0.183158", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MOBQ", "relevance_score": "0.139669", "ticker_sentiment_score": "-0.146374", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNO", "relevance_score": "0.139669", "ticker_sentiment_score": "-0.002561", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCAR", "relevance_score": "0.139669", "ticker_sentiment_score": "-0.316297", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PI", "relevance_score": "0.139669", "ticker_sentiment_score": "-0.201651", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WOLF", "relevance_score": "0.139669", "ticker_sentiment_score": "-0.253695", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CNMD", "relevance_score": "0.070105", "ticker_sentiment_score": "-0.10347", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETAO", "relevance_score": "0.139669", "ticker_sentiment_score": "0.32114", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GETR", "relevance_score": "0.208166", "ticker_sentiment_score": "-0.121109", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.070105", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMND", "relevance_score": "0.139669", "ticker_sentiment_score": "-0.125529", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nexcella, an Immix Biopharma subsidiary, Announces Positive 58-Patient NXC-201 Clinical Data: 100% Overall Response Rate in Light Chain  ( AL )  Amyloidosis; 92% Overall Response Rate in Multiple Myeloma at the EBMT 49th Annual Meeting in Paris", "url": "https://www.globenewswire.com/news-release/2023/04/26/2655734/0/en/Nexcella-an-Immix-Biopharma-subsidiary-Announces-Positive-58-Patient-NXC-201-Clinical-Data-100-Overall-Response-Rate-in-Light-Chain-AL-Amyloidosis-92-Overall-Response-Rate-in-Multi.html", "time_published": "20230426T213000", "authors": ["Immix Biopharma", "Inc."], "summary": "Multiple Myeloma ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/48c8d48f-02a6-456a-b894-0d4cd6f054d6", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.087024, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.124348", "ticker_sentiment_score": "0.024738", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.017835", "ticker_sentiment_score": "0.026214", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nexcella, an Immix Biopharma subsidiary, announces poster presentation at the European Society for Blood and Marrow Transplantation 49th Annual Meeting", "url": "https://www.globenewswire.com/news-release/2023/04/04/2640583/0/en/Nexcella-an-Immix-Biopharma-subsidiary-announces-poster-presentation-at-the-European-Society-for-Blood-and-Marrow-Transplantation-49th-Annual-Meeting.html", "time_published": "20230404T120000", "authors": ["Inc.", "Immix Biopharma"], "summary": "Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Paris, France 23-26 April 2023 Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Paris, France 23-26 ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.01657, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.149038", "ticker_sentiment_score": "0.003913", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nexcella, an Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells", "url": "https://www.globenewswire.com/news-release/2023/03/31/2638581/0/en/Nexcella-an-Immix-Biopharma-Subsidiary-Announces-2023-Haematologica-Editorial-Highlighting-NXC-201-Efficacy-In-The-Context-of-U-S-Food-And-Drug-Administration-Approved-BCMA-CAR-T-C.html", "time_published": "20230331T120000", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, March 31, 2023 ( GLOBE NEWSWIRE ) -- Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) today announced that an editorial written by Maria Sj\u00f6strand and Michel Sadelain of Memorial Sloan Kettering Cancer Center was ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.007124, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.154125", "ticker_sentiment_score": "-0.008006", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.025845", "ticker_sentiment_score": "0.055979", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.025845", "ticker_sentiment_score": "0.055979", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Confirms No Exposure to Silicon Valley Bank or Silvergate Bank", "url": "https://www.globenewswire.com/news-release/2023/03/11/2625263/0/en/Immix-Biopharma-Confirms-No-Exposure-to-Silicon-Valley-Bank-or-Silvergate-Bank.html", "time_published": "20230311T004500", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, March 10, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a biopharmaceutical company pioneering Tissue-Specific Therapeutics ( TSTx ) \u2122 targeting oncology and immuno-dysregulated diseases, today confirms that neither ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": -0.133948, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.822443", "ticker_sentiment_score": "-0.227111", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Nexcella Announces 50 Patients Already Treated with CAR-T NXC-201; Estimates 100-Patient Total Enrollment for U.S. Food and Drug Administration Approval BLA Submission", "url": "https://www.globenewswire.com/news-release/2023/02/27/2616137/0/en/Nexcella-Announces-50-Patients-Already-Treated-with-CAR-T-NXC-201-Estimates-100-Patient-Total-Enrollment-for-U-S-Food-and-Drug-Administration-Approval-BLA-Submission.html", "time_published": "20230227T134500", "authors": ["Immix Biopharma", "Inc."], "summary": "Los Angeles, Feb. 27, 2023 ( GLOBE NEWSWIRE ) -- Nexcella, Inc. ( \"Nexcella\", \"Company\" ) , a biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications and a subsidiary of Immix Biopharma, Inc. ( NASDAQ: IMMX ) , today announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.071258, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.189422", "ticker_sentiment_score": "0.010794", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Doses Additional Patients in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial", "url": "https://www.globenewswire.com/news-release/2023/01/13/2588550/0/en/Immix-Biopharma-Doses-Additional-Patients-in-Ongoing-Phase-1b-2a-IMX-110-Monotherapy-Clinical-Trial.html", "time_published": "20230113T130000", "authors": ["Inc.", "Immix Biopharma"], "summary": "LOS ANGELES, Jan. 13, 2023 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a biopharmaceutical company pioneering Tissue-Specific Therapeutics ( TSTx ) TM targeting oncology and immuno-dysregulated diseases, today announced dosing of an ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.064759, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.282777", "ticker_sentiment_score": "0.059639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.048133", "ticker_sentiment_score": "0.14823", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Subsidiary Nexcella, Inc. Announces Additional Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in Relapsed/Refractory AL Amyloidosis Patients, Duration of Response Not Yet Reached", "url": "https://www.globenewswire.com/news-release/2023/01/06/2584388/0/en/Immix-Biopharma-Subsidiary-Nexcella-Inc-Announces-Additional-Positive-NXC-201-Clinical-Data-Demonstrating-100-Complete-Responses-in-Relapsed-Refractory-AL-Amyloidosis-Patients-Dura.html", "time_published": "20230106T130000", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, CA, Jan. 06, 2023 ( GLOBE NEWSWIRE ) -- Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) today announced that NXC-201 treatment continues to demonstrate 100% complete responses in a total of 6 relapsed/refractory AL ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/119eeb36-9c8f-4380-8356-bd4f1d517330", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.009546, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.216307", "ticker_sentiment_score": "-0.020481", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nexcella, Inc., a subsidiary of Immix Biopharma, announces poster presentation at the European Society for Blood and Marrow Transplantation and European Hematology Association 5th Annual European CAR T-cell Meeting", "url": "https://www.globenewswire.com/news-release/2022/12/28/2580180/0/en/Nexcella-Inc-a-subsidiary-of-Immix-Biopharma-announces-poster-presentation-at-the-European-Society-for-Blood-and-Marrow-Transplantation-and-European-Hematology-Association-5th-Annu.html", "time_published": "20221228T130000", "authors": ["Immix Biopharma", "Inc."], "summary": "Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands February 9-11, 2023 Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.00238, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.202084", "ticker_sentiment_score": "-0.011298", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces 16th Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial", "url": "https://www.globenewswire.com/news-release/2022/12/20/2577016/0/en/Immix-Biopharma-Announces-16th-Patient-Dosing-in-Ongoing-Phase-1b-2a-IMX-110-Monotherapy-Clinical-Trial.html", "time_published": "20221220T130000", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, CA, Dec. 20, 2022 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a biopharmaceutical company pioneering Tissue-Specific Therapeutics ( TSTx ) TM targeting oncology and immuno-dysregulated diseases, today announced another ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.036069, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.283323", "ticker_sentiment_score": "0.010733", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.04823", "ticker_sentiment_score": "0.161834", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ImmixBio Ships Tislelizumab for Patient Dosing in its Combination Clinical Trial with IMX-110 in Advanced Solid Tumors", "url": "https://www.globenewswire.com/news-release/2022/12/19/2576254/0/en/ImmixBio-Ships-Tislelizumab-for-Patient-Dosing-in-its-Combination-Clinical-Trial-with-IMX-110-in-Advanced-Solid-Tumors.html", "time_published": "20221219T130000", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, CA, Dec. 19, 2022 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a biopharmaceutical company pioneering Tissue-Specific Therapeutics ( TSTx ) TM targeting oncology and immuno-dysregulated diseases, today announced that it has ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.021573, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.237668", "ticker_sentiment_score": "0.001848", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.143987", "ticker_sentiment_score": "0.097609", "ticker_sentiment_label": "Neutral"}]}, {"title": "Penny Stocks To Buy? 4 To Watch Before Next Week", "url": "https://pennystocks.com/featured/2022/12/15/penny-stocks-to-buy-4-to-watch-before-next-week/", "time_published": "20221215T184059", "authors": ["J. Samuel"], "summary": "The Stock Market Is Down, But These Penny Stocks Are Moving Higher & Here's Why Penny stocks are known for high-risk and high-reward. They're also known to move disconnected from whatever broader markets are doing, especially when the stock market is down.", "banner_image": "https://pennystocks.com/wp-content/uploads/2021/11/best-low-float-penny-stocks-to-buy-watch-now.jpg", "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.147366, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HCTI", "relevance_score": "0.123315", "ticker_sentiment_score": "0.100694", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.163909", "ticker_sentiment_score": "0.066492", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.041251", "ticker_sentiment_score": "0.013835", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.204072", "ticker_sentiment_score": "0.211082", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IMMX", "relevance_score": "0.082393", "ticker_sentiment_score": "0.125324", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.041251", "ticker_sentiment_score": "0.095965", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Drops Over 300 Points After Fed Raises Key Overnight Interest Rate By 50 bps - Icosavax  ( NASDAQ:ICVX ) , Drive Shack  ( NYSE:DS ) ", "url": "https://www.benzinga.com/news/earnings/22/12/30081422/dow-drops-over-300-points-after-fed-raises-key-overnight-interest-rate-by-50-bps", "time_published": "20221214T193714", "authors": ["Lisa Levin"], "summary": "U.S. stocks turned lower toward the end of trading, after the Federal Reserve announced its policy decision. The Dow traded down 0.99% to 33,771.65 while the NASDAQ fell 1.52% to 11,085.67. The S&P 500 also fell, dropping, 1.12% to 3,974.57. Also check this: Bitcoin Tops $18,000.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/14/image-federal-reserve.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.928139"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.029051, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RNA", "relevance_score": "0.279653", "ticker_sentiment_score": "0.380729", "ticker_sentiment_label": "Bullish"}, {"ticker": "KSPN", "relevance_score": "0.113866", "ticker_sentiment_score": "-0.243028", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NCPL", "relevance_score": "0.113866", "ticker_sentiment_score": "-0.048184", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.113866", "ticker_sentiment_score": "0.108663", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.113866", "ticker_sentiment_score": "0.321439", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ICVX", "relevance_score": "0.113866", "ticker_sentiment_score": "0.284508", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DS", "relevance_score": "0.113866", "ticker_sentiment_score": "0.089718", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.057079", "ticker_sentiment_score": "-0.099681", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:DOGE", "relevance_score": "0.057079", "ticker_sentiment_score": "-0.099681", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Surges Over 100 Points; Charter Communications Shares Slide - Charter Communications  ( NASDAQ:CHTR ) , Cadiz  ( NASDAQ:CDZI ) ", "url": "https://www.benzinga.com/news/earnings/22/12/30080040/dow-surges-over-100-points-charter-communications-shares-slide", "time_published": "20221214T175226", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Wednesday The Dow traded up 0.42% to 34,252.62 while the NASDAQ rose 0.47% to 11,309.44. The S&P 500 also rose, gaining, 0.47% to 4,038.37. Also check this: Bitcoin Tops $18,000.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/14/image26.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.682689"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.033903, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "YMTX", "relevance_score": "0.193207", "ticker_sentiment_score": "0.305283", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GNE-P-A", "relevance_score": "0.064973", "ticker_sentiment_score": "0.160286", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RNA", "relevance_score": "0.193207", "ticker_sentiment_score": "0.22559", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NCPL", "relevance_score": "0.129516", "ticker_sentiment_score": "-0.049895", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHTR", "relevance_score": "0.129516", "ticker_sentiment_score": "0.032663", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.129516", "ticker_sentiment_score": "0.114863", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.129516", "ticker_sentiment_score": "0.33885", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CDZI", "relevance_score": "0.129516", "ticker_sentiment_score": "0.188097", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.064973", "ticker_sentiment_score": "0.110226", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:DOGE", "relevance_score": "0.064973", "ticker_sentiment_score": "0.110226", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Immix Biopharma  ( IMMX )  Shares Are Trading Higher Today - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/general/biotech/22/12/30077362/why-immix-biopharma-shares-are-surging-today", "time_published": "20221214T174327", "authors": ["Vandana Singh"], "summary": "Immix Biopharma Inc IMMX announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 ( formerly HBI0101 ) .", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/14/immx_logo_light__488f179c997464180a2afbac16a901bf.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.079746, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.722944", "ticker_sentiment_score": "0.113191", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma  ( 71% Complete Responses )  and AL Amyloidosis  ( 100% Complete Responses )  - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/pressreleases/22/12/g30073959/immix-biopharma-in-licenses-nxc-201-bcma-targeted-next-generation-car-t-therapy-demonstrating-high", "time_published": "20221214T130000", "authors": ["Globe Newswire"], "summary": "Multiple Myeloma - 85% overall response rate ( 71% CR/sCR ) for NXC-201 at therapeutic dose in an ongoing Phase 1b study in 20 relapsed/refractory patients as of June 27, 2022 data cutoff ( Haematologica https://doi.org/10.3324/haematol.2022.281628 )", "banner_image": "", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.007123, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.371097", "ticker_sentiment_score": "0.023357", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial", "url": "https://www.globenewswire.com/news-release/2022/12/13/2572651/0/en/Immix-Biopharma-Announces-Patient-Dosing-in-Ongoing-Phase-1b-2a-IMX-110-Monotherapy-Clinical-Trial.html", "time_published": "20221213T130000", "authors": ["Inc.", "Immix Biopharma"], "summary": "LOS ANGELES, CA, Dec. 13, 2022 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( \"ImmixBio\", \"Company\", \"We\" or \"Us\" ) , a biopharmaceutical company pioneering Tissue-Specific Therapeutics ( TSTx ) TM targeting oncology and immuno-dysregulated diseases, today announced patient ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.268294", "ticker_sentiment_score": "-0.006146", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.136113", "ticker_sentiment_score": "0.013519", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma Receives Institutional Review Board Approval to Enroll Pediatric Patients in Upcoming IMX-110 Clinical Trial, Key Requirement for U.S. Food and Drug Administration Approval of Rare Pediatric Disease Priority Review Voucher", "url": "https://www.globenewswire.com/news-release/2022/11/11/2554188/0/en/Immix-Biopharma-Receives-Institutional-Review-Board-Approval-to-Enroll-Pediatric-Patients-in-Upcoming-IMX-110-Clinical-Trial-Key-Requirement-for-U-S-Food-and-Drug-Administration-Ap.html", "time_published": "20221111T130000", "authors": ["Inc.", "Immix Biopharma"], "summary": "A photo accompanying this announcement is available at ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/be19ab99-a0c8-4850-a0a4-1592fdc18600?size=2", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.007223, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.233556", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Tuesday - Kearny Financial  ( NASDAQ:KRNY ) , Kaixin Auto Hldgs  ( NASDAQ:KXIN ) ", "url": "https://www.benzinga.com/news/22/11/29504897/stocks-that-hit-52-week-lows-on-tuesday", "time_published": "20221101T154817", "authors": ["Benzinga Insights"], "summary": "On Tuesday, 85 stocks hit new 52-week lows. The largest company by market cap to set a new 52-week low was Mobileye Global MBLY. First Wave BioPharma FWBI was the smallest firm on a market cap basis to set a new 52-week low. XPO Logistics XPO shares dropped the most, trading down 38.12% to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_20446.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.999894"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.096231, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ERNA", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005024", "ticker_sentiment_label": "Neutral"}, {"ticker": "RERE", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.115996", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRE", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.103993", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAZE", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.109995", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMST", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.103993", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCDA", "relevance_score": "0.058759", "ticker_sentiment_score": "0.004017", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005019", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENSC", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.115996", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMAB", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.112607", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBOT", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.115996", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWL", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.115996", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTLT", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005019", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROV", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005019", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005019", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRDS", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005027", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.058759", "ticker_sentiment_score": "0.004017", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMVD", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005027", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSIT", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.109995", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNF", "relevance_score": "0.058759", "ticker_sentiment_score": "0.076509", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRIX", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005027", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWVL", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005027", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.029399", "ticker_sentiment_score": "-0.096731", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNSR", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.112607", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBLY", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.129999", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAAQU", "relevance_score": "0.029399", "ticker_sentiment_score": "0.074099", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.029399", "ticker_sentiment_score": "-0.102443", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIDS", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.109995", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNY", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.115996", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.115996", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELI", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.129999", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPO", "relevance_score": "0.058759", "ticker_sentiment_score": "0.069596", "ticker_sentiment_label": "Neutral"}, {"ticker": "OG", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005019", "ticker_sentiment_label": "Neutral"}, {"ticker": "NURO", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "VYNT", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005019", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSR", "relevance_score": "0.058759", "ticker_sentiment_score": "0.004017", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005019", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "QLGN", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNGY", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.058759", "ticker_sentiment_score": "0.194914", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QCRH", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.119649", "ticker_sentiment_label": "Neutral"}, {"ticker": "KXIN", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXLA", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005019", "ticker_sentiment_label": "Neutral"}, {"ticker": "QBTS", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.115996", "ticker_sentiment_label": "Neutral"}, {"ticker": "SST", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.115996", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKNA", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.103993", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.1172", "ticker_sentiment_score": "-0.123438", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAX", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005027", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBRA", "relevance_score": "0.058759", "ticker_sentiment_score": "0.005019", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.129999", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at the 2022 ThinkEquity Conference on October 26 - Immix Biopharma  ( NASDAQ:IMMX ) ", "url": "https://www.benzinga.com/pressreleases/22/10/g29394221/immix-biopharma-to-present-milestones-achieved-to-enable-kick-off-of-2-imx-110-clinical-trials-at-", "time_published": "20221025T120032", "authors": ["Globe Newswire"], "summary": "A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fe1f9d2e-f230-494b-9bb9-6b910a14f2aa LOS ANGELES, Oct. 25, 2022 ( GLOBE NEWSWIRE ) -- Immix Biopharma, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.00954, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MAORF", "relevance_score": "0.047844", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.281153", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.047844", "ticker_sentiment_score": "0.118825", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at the 2022 ThinkEquity Conference on October 26", "url": "https://www.globenewswire.com/news-release/2022/10/25/2540814/0/en/Immix-Biopharma-to-Present-Milestones-Achieved-to-Enable-Kick-Off-of-2-IMX-110-Clinical-Trials-at-the-2022-ThinkEquity-Conference-on-October-26.html", "time_published": "20221025T120000", "authors": ["Immix Biopharma", "Inc."], "summary": "A photo accompanying this announcement is available at ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fe1f9d2e-f230-494b-9bb9-6b910a14f2aa?size=2", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.011957, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MAORF", "relevance_score": "0.050572", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.296463", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.050572", "ticker_sentiment_score": "0.119319", "ticker_sentiment_label": "Neutral"}]}, {"title": " ( IMMX )  - ImmixBio Completes GMP Manufacturing of Scaled-Up Batch of IMX-110 for Clinical Trials", "url": "https://www.benzinga.com/pressreleases/22/09/g28780904/immixbio-completes-gmp-manufacturing-of-scaled-up-batch-of-imx-110-for-clinical-trials", "time_published": "20220907T160534", "authors": ["Globe Newswire"], "summary": "Scaled-up, proprietary GMP manufacturing process to be utilized in 2 clinical trials: 2022 planned monotherapy IMX-110 Clinical Trial in soft tissue sarcoma ( \"STS\" ) 2022 planned combination IMX-110 + BeiGene anti-PD-1 tislelizumab Clinical Trial in advanced solid tumors", "banner_image": "", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.040696, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.197011", "ticker_sentiment_score": "-0.011139", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.148426", "ticker_sentiment_score": "0.110953", "ticker_sentiment_label": "Neutral"}]}, {"title": "ImmixBio Completes GMP Manufacturing of Scaled-Up Batch of IMX-110 for Clinical Trials", "url": "https://www.globenewswire.com/news-release/2022/09/07/2511863/0/en/ImmixBio-Completes-GMP-Manufacturing-of-Scaled-Up-Batch-of-IMX-110-for-Clinical-Trials.html", "time_published": "20220907T160500", "authors": ["Inc.", "Immix Biopharma"], "summary": "A photo accompanying this announcement is available at ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/49d68ad5-624b-46b9-8f15-cc07b6717d92?size=2", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.021638, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.211652", "ticker_sentiment_score": "-0.011819", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.106778", "ticker_sentiment_score": "0.086371", "ticker_sentiment_label": "Neutral"}]}, {"title": "38 Stocks Moving In Tuesday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/06/27592553/38-stocks-moving-in-tuesdays-mid-day-session", "time_published": "20220607T160117", "authors": ["Lisa Levin"], "summary": "Gainers Kiromic BioPharma, Inc. ( NASDAQ: KRBP ) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma Delta T cell allogeneic therapies. JanOne Inc. ( NASDAQ: JAN ) shares jumped 47.8% to $3.69", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/07/mid-day_movers_image.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.003897, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GTLB", "relevance_score": "0.126617", "ticker_sentiment_score": "0.003715", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVG", "relevance_score": "0.126617", "ticker_sentiment_score": "-0.002122", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.126617", "ticker_sentiment_score": "0.000881", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.188928", "ticker_sentiment_score": "0.005537", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.126617", "ticker_sentiment_score": "0.001242", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTH", "relevance_score": "0.126617", "ticker_sentiment_score": "-0.00014", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.188928", "ticker_sentiment_score": "0.02383", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.126617", "ticker_sentiment_score": "0.007837", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUBT", "relevance_score": "0.126617", "ticker_sentiment_score": "0.001429", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTSI", "relevance_score": "0.126617", "ticker_sentiment_score": "-0.00246", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHX", "relevance_score": "0.126617", "ticker_sentiment_score": "0.000409", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRBP", "relevance_score": "0.126617", "ticker_sentiment_score": "0.006326", "ticker_sentiment_label": "Neutral"}, {"ticker": "NINE", "relevance_score": "0.126617", "ticker_sentiment_score": "9.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIOX", "relevance_score": "0.126617", "ticker_sentiment_score": "0.001248", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEGG", "relevance_score": "0.063509", "ticker_sentiment_score": "0.000777", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERU", "relevance_score": "0.188928", "ticker_sentiment_score": "0.001856", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLY", "relevance_score": "0.126617", "ticker_sentiment_score": "-0.00023", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.188928", "ticker_sentiment_score": "0.000298", "ticker_sentiment_label": "Neutral"}, {"ticker": "METC", "relevance_score": "0.188928", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.188928", "ticker_sentiment_score": "0.001791", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLOP", "relevance_score": "0.126617", "ticker_sentiment_score": "0.000682", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSGM", "relevance_score": "0.126617", "ticker_sentiment_score": "0.001899", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.126617", "ticker_sentiment_score": "0.000557", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGAP", "relevance_score": "0.063509", "ticker_sentiment_score": "0.006719", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSS", "relevance_score": "0.126617", "ticker_sentiment_score": "0.006719", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCTH", "relevance_score": "0.188928", "ticker_sentiment_score": "0.004633", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIFR", "relevance_score": "0.126617", "ticker_sentiment_score": "-0.001664", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.126617", "ticker_sentiment_score": "-0.004888", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLOG-P-A", "relevance_score": "0.063509", "ticker_sentiment_score": "0.000682", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCAN", "relevance_score": "0.126617", "ticker_sentiment_score": "3.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAN", "relevance_score": "0.126617", "ticker_sentiment_score": "0.001273", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCEL", "relevance_score": "0.126617", "ticker_sentiment_score": "0.002819", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.126617", "ticker_sentiment_score": "0.000928", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRNA", "relevance_score": "0.126617", "ticker_sentiment_score": "-0.00062", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVFY", "relevance_score": "0.126617", "ticker_sentiment_score": "0.001779", "ticker_sentiment_label": "Neutral"}]}, {"title": "74 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/06/27539006/74-biggest-movers-from-yesterday", "time_published": "20220603T095047", "authors": ["Lisa Levin"], "summary": "Gainers NRx Pharmaceuticals, Inc. ( NASDAQ: NRXP ) shares gained 47.5% to settle at $0.8436 on Thursday. Based on the review of approximately 460 patients, Data Safety and Monitoring Board ( DSMB ) recently determined that the evaluation of NRx Pharmaceuticals' Zyesami ( aviptadil ) should cea", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/03/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.999986"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.000692, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.052871", "ticker_sentiment_score": "0.005851", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGLE", "relevance_score": "0.079234", "ticker_sentiment_score": "-0.015895", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHI", "relevance_score": "0.052871", "ticker_sentiment_score": "0.000769", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTLB", "relevance_score": "0.052871", "ticker_sentiment_score": "0.001814", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.052871", "ticker_sentiment_score": "0.01414", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTV", "relevance_score": "0.052871", "ticker_sentiment_score": "-0.007999", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTX", "relevance_score": "0.052871", "ticker_sentiment_score": "0.004833", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTA", "relevance_score": "0.052871", "ticker_sentiment_score": "0.009615", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTP", "relevance_score": "0.105511", "ticker_sentiment_score": "0.00591", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEEV", "relevance_score": "0.052871", "ticker_sentiment_score": "0.079921", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISA", "relevance_score": "0.052871", "ticker_sentiment_score": "0.001738", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDB", "relevance_score": "0.052871", "ticker_sentiment_score": "0.098575", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.02645", "ticker_sentiment_score": "-0.008889", "ticker_sentiment_label": "Neutral"}, {"ticker": "TALK", "relevance_score": "0.052871", "ticker_sentiment_score": "0.040691", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZSAN", "relevance_score": "0.052871", "ticker_sentiment_score": "-0.001109", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNS", "relevance_score": "0.079234", "ticker_sentiment_score": "-0.036277", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.079234", "ticker_sentiment_score": "0.027029", "ticker_sentiment_label": "Neutral"}, {"ticker": "INNV", "relevance_score": "0.052871", "ticker_sentiment_score": "0.003109", "ticker_sentiment_label": "Neutral"}, {"ticker": "YI", "relevance_score": "0.052871", "ticker_sentiment_score": "0.009249", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNCE", "relevance_score": "0.052871", "ticker_sentiment_score": "0.00059", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTG", "relevance_score": "0.052871", "ticker_sentiment_score": "0.042312", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.079234", "ticker_sentiment_score": "0.002085", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.052871", "ticker_sentiment_score": "0.002931", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.052871", "ticker_sentiment_score": "0.079039", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.052871", "ticker_sentiment_score": "0.027604", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.079234", "ticker_sentiment_score": "-0.053543", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.052871", "ticker_sentiment_score": "0.029648", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.052871", "ticker_sentiment_score": "0.000913", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFOI", "relevance_score": "0.052871", "ticker_sentiment_score": "0.026453", "ticker_sentiment_label": "Neutral"}, {"ticker": "BON", "relevance_score": "0.052871", "ticker_sentiment_score": "0.223904", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ECOR", "relevance_score": "0.052871", "ticker_sentiment_score": "0.002399", "ticker_sentiment_label": "Neutral"}, {"ticker": "REDU", "relevance_score": "0.052871", "ticker_sentiment_score": "0.000654", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.052871", "ticker_sentiment_score": "0.002604", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDO", "relevance_score": "0.052871", "ticker_sentiment_score": "0.106665", "ticker_sentiment_label": "Neutral"}, {"ticker": "AI", "relevance_score": "0.052871", "ticker_sentiment_score": "-0.001514", "ticker_sentiment_label": "Neutral"}, {"ticker": "MICS", "relevance_score": "0.052871", "ticker_sentiment_score": "0.01291", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.052871", "ticker_sentiment_score": "-0.001617", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.052871", "ticker_sentiment_score": "0.002139", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.052871", "ticker_sentiment_score": "0.012978", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.052871", "ticker_sentiment_score": "-0.000648", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.079234", "ticker_sentiment_score": "0.013612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.052871", "ticker_sentiment_score": "0.012082", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCP", "relevance_score": "0.052871", "ticker_sentiment_score": "0.3627", "ticker_sentiment_label": "Bullish"}, {"ticker": "APRN", "relevance_score": "0.052871", "ticker_sentiment_score": "0.035467", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRCL", "relevance_score": "0.079234", "ticker_sentiment_score": "0.003743", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEVO", "relevance_score": "0.079234", "ticker_sentiment_score": "0.175865", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IMTE", "relevance_score": "0.052871", "ticker_sentiment_score": "0.00311", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVIS", "relevance_score": "0.052871", "ticker_sentiment_score": "0.000593", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAI", "relevance_score": "0.079234", "ticker_sentiment_score": "-0.004406", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.052871", "ticker_sentiment_score": "-0.761817", "ticker_sentiment_label": "Bearish"}, {"ticker": "CNEY", "relevance_score": "0.052871", "ticker_sentiment_score": "-0.001159", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEKE", "relevance_score": "0.079234", "ticker_sentiment_score": "0.108733", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.052871", "ticker_sentiment_score": "0.003285", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.052871", "ticker_sentiment_score": "-0.003561", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQMS", "relevance_score": "0.052871", "ticker_sentiment_score": "0.001627", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.02645", "ticker_sentiment_score": "-0.761817", "ticker_sentiment_label": "Bearish"}, {"ticker": "INTZ", "relevance_score": "0.079234", "ticker_sentiment_score": "0.0085", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLGN", "relevance_score": "0.079234", "ticker_sentiment_score": "-0.044765", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.02645", "ticker_sentiment_score": "0.002085", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.052871", "ticker_sentiment_score": "0.005547", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYXH", "relevance_score": "0.052871", "ticker_sentiment_score": "0.001172", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.052871", "ticker_sentiment_score": "0.001222", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.052871", "ticker_sentiment_score": "0.001069", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPTX", "relevance_score": "0.052871", "ticker_sentiment_score": "0.019757", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMUX", "relevance_score": "0.052871", "ticker_sentiment_score": "-0.126585", "ticker_sentiment_label": "Neutral"}, {"ticker": "LWLG", "relevance_score": "0.052871", "ticker_sentiment_score": "0.001537", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.079234", "ticker_sentiment_score": "-0.008889", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYR", "relevance_score": "0.052871", "ticker_sentiment_score": "0.00953", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLNW", "relevance_score": "0.052871", "ticker_sentiment_score": "0.003762", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.079234", "ticker_sentiment_score": "0.004271", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.079234", "ticker_sentiment_score": "0.058845", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.052871", "ticker_sentiment_score": "0.00385", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNA", "relevance_score": "0.052871", "ticker_sentiment_score": "0.007855", "ticker_sentiment_label": "Neutral"}, {"ticker": "LE", "relevance_score": "0.052871", "ticker_sentiment_score": "0.064783", "ticker_sentiment_label": "Neutral"}]}, {"title": "53 Stocks Moving In Thursday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/06/27527395/53-stocks-moving-in-thursdays-mid-day-session", "time_published": "20220602T161759", "authors": ["Lisa Levin"], "summary": "Gainers Repare Therapeutics Inc. ( NASDAQ: RPTX ) jumped 38.1% to $12.08 after the company announced it has entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of camonsertib. Repare will receive a $125 million upfront payment and is el", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/02/mid-day_movers_image.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.999986"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": -0.023377, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.011076", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGLE", "relevance_score": "0.1107", "ticker_sentiment_score": "-0.019496", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHI", "relevance_score": "0.073932", "ticker_sentiment_score": "0.000875", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.000863", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTV", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.001275", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTX", "relevance_score": "0.073932", "ticker_sentiment_score": "0.000396", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTA", "relevance_score": "0.073932", "ticker_sentiment_score": "0.004681", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTP", "relevance_score": "0.147231", "ticker_sentiment_score": "0.003706", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEEV", "relevance_score": "0.073932", "ticker_sentiment_score": "0.014927", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISA", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.003697", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDB", "relevance_score": "0.073932", "ticker_sentiment_score": "0.052578", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.037006", "ticker_sentiment_score": "-0.009221", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZSAN", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.002883", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.1107", "ticker_sentiment_score": "0.008504", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNCE", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.013351", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTG", "relevance_score": "0.073932", "ticker_sentiment_score": "0.039886", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.1107", "ticker_sentiment_score": "0.002216", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.073932", "ticker_sentiment_score": "0.012817", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.073932", "ticker_sentiment_score": "0.026791", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.073932", "ticker_sentiment_score": "0.003968", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.073932", "ticker_sentiment_score": "0.006335", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.073932", "ticker_sentiment_score": "0.000635", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFOI", "relevance_score": "0.073932", "ticker_sentiment_score": "0.00207", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOR", "relevance_score": "0.073932", "ticker_sentiment_score": "0.002105", "ticker_sentiment_label": "Neutral"}, {"ticker": "REDU", "relevance_score": "0.073932", "ticker_sentiment_score": "0.000514", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDO", "relevance_score": "0.073932", "ticker_sentiment_score": "0.148235", "ticker_sentiment_label": "Neutral"}, {"ticker": "AI", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.002022", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.002129", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.001624", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.000544", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMTX", "relevance_score": "0.1107", "ticker_sentiment_score": "-0.022599", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.1107", "ticker_sentiment_score": "0.008863", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.073932", "ticker_sentiment_score": "0.02117", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.073932", "ticker_sentiment_score": "0.012814", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEVO", "relevance_score": "0.1107", "ticker_sentiment_score": "0.120329", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMTE", "relevance_score": "0.073932", "ticker_sentiment_score": "0.008049", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVIS", "relevance_score": "0.073932", "ticker_sentiment_score": "0.002157", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.757223", "ticker_sentiment_label": "Bearish"}, {"ticker": "CNEY", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.000892", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEKE", "relevance_score": "0.1107", "ticker_sentiment_score": "0.114508", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.037006", "ticker_sentiment_score": "-0.757223", "ticker_sentiment_label": "Bearish"}, {"ticker": "SZCRF", "relevance_score": "0.037006", "ticker_sentiment_score": "0.002216", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.073932", "ticker_sentiment_score": "0.001405", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.073932", "ticker_sentiment_score": "0.001011", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPTX", "relevance_score": "0.073932", "ticker_sentiment_score": "0.015477", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMUX", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.348475", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LWLG", "relevance_score": "0.073932", "ticker_sentiment_score": "0.001324", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.1107", "ticker_sentiment_score": "-0.009221", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYR", "relevance_score": "0.073932", "ticker_sentiment_score": "0.006504", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLNW", "relevance_score": "0.073932", "ticker_sentiment_score": "-0.021435", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.1107", "ticker_sentiment_score": "0.022263", "ticker_sentiment_label": "Neutral"}, {"ticker": "LE", "relevance_score": "0.073932", "ticker_sentiment_score": "0.02647", "ticker_sentiment_label": "Neutral"}]}, {"title": "12 Health Care Stocks Moving In Thursday's Pre-Market Session", "url": "https://www.benzinga.com/trading-ideas/movers/22/06/27519309/12-health-care-stocks-moving-in-thursdays-pre-market-session", "time_published": "20220602T122608", "authors": ["Benzinga Insights"], "summary": "Gainers Immix Biopharma ( NASDAQ:IMMX ) stock increased by 39.5% to $2.58 during Thursday's pre-market session. The market value of their outstanding shares is at $35.8 million. Repare Therapeutics ( NASDAQ:RPTX ) shares moved upwards by 26.17% to $11.04. The company's market cap stands at $462.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_9665.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}], "overall_sentiment_score": -0.016371, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMMB", "relevance_score": "0.277748", "ticker_sentiment_score": "0.002668", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.277748", "ticker_sentiment_score": "0.00531", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPTX", "relevance_score": "0.277748", "ticker_sentiment_score": "0.00517", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMUX", "relevance_score": "0.277748", "ticker_sentiment_score": "-0.011078", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.277748", "ticker_sentiment_score": "-0.008248", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.277748", "ticker_sentiment_score": "0.011838", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDSB", "relevance_score": "0.277748", "ticker_sentiment_score": "0.002387", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTA", "relevance_score": "0.277748", "ticker_sentiment_score": "0.001739", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENOB", "relevance_score": "0.277748", "ticker_sentiment_score": "0.000656", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.277748", "ticker_sentiment_score": "0.007751", "ticker_sentiment_label": "Neutral"}]}, {"title": "24 Stocks Moving in Thursday's Pre-Market Session", "url": "https://www.benzinga.com/news/22/06/27517530/24-stocks-moving-in-thursdays-pre-market-session", "time_published": "20220602T105538", "authors": ["Lisa Levin"], "summary": "Gainers Immix Biopharma, Inc. ( NASDAQ: IMMX ) rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma ( STS ) . Missfresh Limited ( NASDAQ: MF ) rose 27.3% to $0", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/02/premkt_movers.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.922939"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.04567, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.130748", "ticker_sentiment_score": "-0.02322", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNET", "relevance_score": "0.130748", "ticker_sentiment_score": "0.000176", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.130748", "ticker_sentiment_score": "0.000886", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.065595", "ticker_sentiment_score": "-0.726258", "ticker_sentiment_label": "Bearish"}, {"ticker": "MDB", "relevance_score": "0.130748", "ticker_sentiment_score": "0.06282", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.065595", "ticker_sentiment_score": "-0.004128", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHP", "relevance_score": "0.130748", "ticker_sentiment_score": "-0.00708", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZSAN", "relevance_score": "0.195025", "ticker_sentiment_score": "-0.050098", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.195025", "ticker_sentiment_score": "0.012616", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.130748", "ticker_sentiment_score": "0.031178", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.195025", "ticker_sentiment_score": "0.000806", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.130748", "ticker_sentiment_score": "0.009189", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFOI", "relevance_score": "0.130748", "ticker_sentiment_score": "0.002647", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPTX", "relevance_score": "0.195025", "ticker_sentiment_score": "0.005454", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTAI", "relevance_score": "0.130748", "ticker_sentiment_score": "0.001124", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.195025", "ticker_sentiment_score": "-0.004128", "ticker_sentiment_label": "Neutral"}, {"ticker": "AI", "relevance_score": "0.130748", "ticker_sentiment_score": "-0.000611", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.195025", "ticker_sentiment_score": "0.02579", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.130748", "ticker_sentiment_score": "-0.00237", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.130748", "ticker_sentiment_score": "-4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGRX", "relevance_score": "0.130748", "ticker_sentiment_score": "0.001419", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRCA", "relevance_score": "0.130748", "ticker_sentiment_score": "0.002327", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.130748", "ticker_sentiment_score": "0.009905", "ticker_sentiment_label": "Neutral"}, {"ticker": "METX", "relevance_score": "0.130748", "ticker_sentiment_score": "-0.00046", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVB", "relevance_score": "0.130748", "ticker_sentiment_score": "0.000739", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.130748", "ticker_sentiment_score": "-0.726258", "ticker_sentiment_label": "Bearish"}]}, {"title": "77 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/06/27492435/77-biggest-movers-from-yesterday", "time_published": "20220601T090222", "authors": ["Lisa Levin"], "summary": "Gainers TherapeuticsMD, Inc. ( NASDAQ: TXMD ) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners. JanOne Inc. ( NASDAQ: JAN ) gained 66.5% to close at $3.73 after", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/01/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.00474, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSTR", "relevance_score": "0.057208", "ticker_sentiment_score": "0.002982", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTLK", "relevance_score": "0.085721", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTT", "relevance_score": "0.057208", "ticker_sentiment_score": "0.00702", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRO", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.004948", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.045726", "ticker_sentiment_label": "Neutral"}, {"ticker": "SASI", "relevance_score": "0.057208", "ticker_sentiment_score": "0.002746", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTV", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.018349", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISA", "relevance_score": "0.057208", "ticker_sentiment_score": "0.001103", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZFD", "relevance_score": "0.057208", "ticker_sentiment_score": "0.000121", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELB", "relevance_score": "0.057208", "ticker_sentiment_score": "0.010515", "ticker_sentiment_label": "Neutral"}, {"ticker": "SESN", "relevance_score": "0.057208", "ticker_sentiment_score": "0.003129", "ticker_sentiment_label": "Neutral"}, {"ticker": "LX", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.115448", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXEH", "relevance_score": "0.057208", "ticker_sentiment_score": "0.001882", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSPR", "relevance_score": "0.057208", "ticker_sentiment_score": "0.000191", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.057208", "ticker_sentiment_score": "0.029286", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.085721", "ticker_sentiment_score": "0.005707", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPOP", "relevance_score": "0.057208", "ticker_sentiment_score": "0.002186", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMBL", "relevance_score": "0.085721", "ticker_sentiment_score": "0.005773", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCT", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.033342", "ticker_sentiment_label": "Neutral"}, {"ticker": "TALS", "relevance_score": "0.057208", "ticker_sentiment_score": "0.005607", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.057208", "ticker_sentiment_score": "0.01592", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDU", "relevance_score": "0.057208", "ticker_sentiment_score": "0.002005", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEGG", "relevance_score": "0.085721", "ticker_sentiment_score": "0.087159", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.057208", "ticker_sentiment_score": "0.001919", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARPS", "relevance_score": "0.057208", "ticker_sentiment_score": "0.002324", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.057208", "ticker_sentiment_score": "0.001419", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNTR", "relevance_score": "0.057208", "ticker_sentiment_score": "0.006816", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLDX", "relevance_score": "0.057208", "ticker_sentiment_score": "0.000931", "ticker_sentiment_label": "Neutral"}, {"ticker": "REDU", "relevance_score": "0.057208", "ticker_sentiment_score": "0.001741", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUY", "relevance_score": "0.028623", "ticker_sentiment_score": "0.019571", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMR", "relevance_score": "0.057208", "ticker_sentiment_score": "0.002419", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMMT", "relevance_score": "0.085721", "ticker_sentiment_score": "-0.035533", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCLD", "relevance_score": "0.057208", "ticker_sentiment_score": "0.002735", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.057208", "ticker_sentiment_score": "0.00113", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSLS", "relevance_score": "0.057208", "ticker_sentiment_score": "0.00144", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.057208", "ticker_sentiment_score": "0.004435", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.018045", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCH", "relevance_score": "0.028623", "ticker_sentiment_score": "0.00702", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.057208", "ticker_sentiment_score": "0.014325", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.057208", "ticker_sentiment_score": "0.003676", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAMI", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.002036", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.020997", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELEV", "relevance_score": "0.085721", "ticker_sentiment_score": "0.008014", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMM", "relevance_score": "0.057208", "ticker_sentiment_score": "0.006113", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANF", "relevance_score": "0.057208", "ticker_sentiment_score": "0.001344", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPIH", "relevance_score": "0.057208", "ticker_sentiment_score": "0.004486", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.057208", "ticker_sentiment_score": "0.022459", "ticker_sentiment_label": "Neutral"}, {"ticker": "VS", "relevance_score": "0.057208", "ticker_sentiment_score": "-9.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAL", "relevance_score": "0.057208", "ticker_sentiment_score": "0.02993", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLHG", "relevance_score": "0.085721", "ticker_sentiment_score": "-0.078369", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEKE", "relevance_score": "0.057208", "ticker_sentiment_score": "0.051377", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.085721", "ticker_sentiment_score": "-0.033614", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFI", "relevance_score": "0.057208", "ticker_sentiment_score": "0.019571", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXI", "relevance_score": "0.085721", "ticker_sentiment_score": "-0.016553", "ticker_sentiment_label": "Neutral"}, {"ticker": "BORR", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.000965", "ticker_sentiment_label": "Neutral"}, {"ticker": "PMVP", "relevance_score": "0.057208", "ticker_sentiment_score": "0.000168", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMTI", "relevance_score": "0.085721", "ticker_sentiment_score": "0.002091", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.057208", "ticker_sentiment_score": "0.008459", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.057208", "ticker_sentiment_score": "0.009122", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSC", "relevance_score": "0.057208", "ticker_sentiment_score": "0.009046", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXPF", "relevance_score": "0.028623", "ticker_sentiment_score": "-0.016553", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGRU", "relevance_score": "0.085721", "ticker_sentiment_score": "0.000381", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVDL", "relevance_score": "0.085721", "ticker_sentiment_score": "0.011822", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAMOD", "relevance_score": "0.028623", "ticker_sentiment_score": "0.008231", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDSB", "relevance_score": "0.057208", "ticker_sentiment_score": "-0.017174", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHG", "relevance_score": "0.085721", "ticker_sentiment_score": "0.013133", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSGM", "relevance_score": "0.057208", "ticker_sentiment_score": "0.001845", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.057208", "ticker_sentiment_score": "0.000325", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKKT", "relevance_score": "0.057208", "ticker_sentiment_score": "0.018049", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAB", "relevance_score": "0.057208", "ticker_sentiment_score": "0.017495", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.057208", "ticker_sentiment_score": "0.0021", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKSY", "relevance_score": "0.057208", "ticker_sentiment_score": "0.002214", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.057208", "ticker_sentiment_score": "0.001761", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRRX", "relevance_score": "0.085721", "ticker_sentiment_score": "-0.162274", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JAN", "relevance_score": "0.057208", "ticker_sentiment_score": "0.008509", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKNA", "relevance_score": "0.085721", "ticker_sentiment_score": "-0.007183", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICVX", "relevance_score": "0.085721", "ticker_sentiment_score": "-0.003261", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.057208", "ticker_sentiment_score": "0.010905", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.057208", "ticker_sentiment_score": "0.010905", "ticker_sentiment_label": "Neutral"}]}, {"title": "40 Stocks Moving In Tuesday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/05/27478950/40-stocks-moving-in-tuesdays-mid-day-session", "time_published": "20220531T160405", "authors": ["Lisa Levin"], "summary": "Gainers TherapeuticsMD, Inc. ( NASDAQ: TXMD ) shares jumped 360.8% to $9.86 after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners. JanOne Inc. ( NASDAQ: JAN ) surged 85.7% to $4.16 after the company announced it sol", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/31/mid-day_movers_image.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.004746, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSTR", "relevance_score": "0.115787", "ticker_sentiment_score": "0.003553", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTT", "relevance_score": "0.115787", "ticker_sentiment_score": "0.006405", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRO", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.002113", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.055111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTV", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.002812", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFI", "relevance_score": "0.172919", "ticker_sentiment_score": "0.017029", "ticker_sentiment_label": "Neutral"}, {"ticker": "LX", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.005074", "ticker_sentiment_label": "Neutral"}, {"ticker": "BORR", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.00426", "ticker_sentiment_label": "Neutral"}, {"ticker": "PMVP", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.004141", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCT", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.026995", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.115787", "ticker_sentiment_score": "0.000376", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDU", "relevance_score": "0.115787", "ticker_sentiment_score": "0.000142", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.115787", "ticker_sentiment_score": "9.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.115787", "ticker_sentiment_score": "0.000881", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEGG", "relevance_score": "0.172919", "ticker_sentiment_score": "0.06206", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARPS", "relevance_score": "0.115787", "ticker_sentiment_score": "0.002354", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNTR", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.000114", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGRU", "relevance_score": "0.172919", "ticker_sentiment_score": "9.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVDL", "relevance_score": "0.172919", "ticker_sentiment_score": "0.004048", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUY", "relevance_score": "0.172919", "ticker_sentiment_score": "0.017029", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMR", "relevance_score": "0.115787", "ticker_sentiment_score": "0.00121", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHG", "relevance_score": "0.172919", "ticker_sentiment_score": "0.020532", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.000377", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKKT", "relevance_score": "0.115787", "ticker_sentiment_score": "0.013855", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAB", "relevance_score": "0.115787", "ticker_sentiment_score": "0.005226", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.115787", "ticker_sentiment_score": "0.001086", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKSY", "relevance_score": "0.115787", "ticker_sentiment_score": "0.003986", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.060259", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCH", "relevance_score": "0.058047", "ticker_sentiment_score": "0.006405", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.115787", "ticker_sentiment_score": "0.000591", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAN", "relevance_score": "0.115787", "ticker_sentiment_score": "0.004555", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.115787", "ticker_sentiment_score": "0.000124", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELEV", "relevance_score": "0.172919", "ticker_sentiment_score": "0.00459", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMM", "relevance_score": "0.115787", "ticker_sentiment_score": "0.002088", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANF", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.000191", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.115787", "ticker_sentiment_score": "0.006849", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICVX", "relevance_score": "0.172919", "ticker_sentiment_score": "-0.006524", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.115787", "ticker_sentiment_score": "0.009003", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.115787", "ticker_sentiment_score": "0.009003", "ticker_sentiment_label": "Neutral"}]}, {"title": "88 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/05/27435426/88-biggest-movers-from-yesterday", "time_published": "20220527T074118", "authors": ["Lisa Levin"], "summary": "Gainers Creatd, Inc. ( NASDAQ: CRTD ) shares jumped 58.5% to close at $1.28 on Thursday. Creatd's board approved a rights offering of up to $40 million for 20 million shares at $2 per unit. Apyx Medical Corporation ( NASDAQ: APYX ) rose 51.9% to settle at $5.62 after the company received the FDA", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/27/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.015525, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRTD", "relevance_score": "0.044161", "ticker_sentiment_score": "0.027652", "ticker_sentiment_label": "Neutral"}, {"ticker": "DG", "relevance_score": "0.044161", "ticker_sentiment_score": "0.034736", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRA", "relevance_score": "0.044161", "ticker_sentiment_score": "0.000262", "ticker_sentiment_label": "Neutral"}, {"ticker": "VGFC", "relevance_score": "0.044161", "ticker_sentiment_score": "0.878167", "ticker_sentiment_label": "Bullish"}, {"ticker": "KHC", "relevance_score": "0.044161", "ticker_sentiment_score": "0.002151", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPN", "relevance_score": "0.044161", "ticker_sentiment_score": "0.00313", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.066199", "ticker_sentiment_score": "0.003", "ticker_sentiment_label": "Neutral"}, {"ticker": "TALK", "relevance_score": "0.044161", "ticker_sentiment_score": "0.004822", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.044161", "ticker_sentiment_score": "0.000697", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.044161", "ticker_sentiment_score": "0.0066", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCTI", "relevance_score": "0.066199", "ticker_sentiment_score": "-0.027629", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.044161", "ticker_sentiment_score": "0.001213", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBW", "relevance_score": "0.044161", "ticker_sentiment_score": "0.044051", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDH", "relevance_score": "0.044161", "ticker_sentiment_score": "0.005685", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.066199", "ticker_sentiment_score": "-0.01873", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.044161", "ticker_sentiment_score": "0.002429", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSAT", "relevance_score": "0.044161", "ticker_sentiment_score": "0.000515", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYDEV", "relevance_score": "0.022089", "ticker_sentiment_score": "-0.000349", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.044161", "ticker_sentiment_score": "0.000123", "ticker_sentiment_label": "Neutral"}, {"ticker": "QK", "relevance_score": "0.044161", "ticker_sentiment_score": "0.001422", "ticker_sentiment_label": "Neutral"}, {"ticker": "EZFL", "relevance_score": "0.044161", "ticker_sentiment_score": "0.001768", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENOB", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.04485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BABA", "relevance_score": "0.044161", "ticker_sentiment_score": "0.041357", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEAT", "relevance_score": "0.044161", "ticker_sentiment_score": "0.009794", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTC", "relevance_score": "0.066199", "ticker_sentiment_score": "-0.011095", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.066199", "ticker_sentiment_score": "-0.000228", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.015177", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLTR", "relevance_score": "0.044161", "ticker_sentiment_score": "0.034713", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.044161", "ticker_sentiment_score": "0.003078", "ticker_sentiment_label": "Neutral"}, {"ticker": "BROS", "relevance_score": "0.044161", "ticker_sentiment_score": "0.010102", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.044161", "ticker_sentiment_score": "0.00404", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.044161", "ticker_sentiment_score": "0.002397", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRTS", "relevance_score": "0.066199", "ticker_sentiment_score": "0.006227", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRKR", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.01232", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.044161", "ticker_sentiment_score": "0.016859", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXC", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.458009", "ticker_sentiment_label": "Bearish"}, {"ticker": "RDBX", "relevance_score": "0.044161", "ticker_sentiment_score": "0.0032", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.066199", "ticker_sentiment_score": "0.006261", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.044161", "ticker_sentiment_score": "0.024199", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIG", "relevance_score": "0.044161", "ticker_sentiment_score": "0.000997", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOGU", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.014063", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.014849", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.044161", "ticker_sentiment_score": "0.001398", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.044161", "ticker_sentiment_score": "0.011774", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRE", "relevance_score": "0.044161", "ticker_sentiment_score": "0.00603", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIMI", "relevance_score": "0.044161", "ticker_sentiment_score": "0.001416", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.044161", "ticker_sentiment_score": "0.000408", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIG", "relevance_score": "0.066199", "ticker_sentiment_score": "-0.000349", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYES", "relevance_score": "0.066199", "ticker_sentiment_score": "0.009131", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.038175", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCR", "relevance_score": "0.022089", "ticker_sentiment_score": "0.0064", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZTEK", "relevance_score": "0.044161", "ticker_sentiment_score": "0.020833", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRA", "relevance_score": "0.044161", "ticker_sentiment_score": "0.014157", "ticker_sentiment_label": "Neutral"}, {"ticker": "M", "relevance_score": "0.022089", "ticker_sentiment_score": "0.027468", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNET", "relevance_score": "0.066199", "ticker_sentiment_score": "0.016834", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELDN", "relevance_score": "0.066199", "ticker_sentiment_score": "-0.003185", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.066199", "ticker_sentiment_score": "-0.000832", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.066199", "ticker_sentiment_score": "0.012427", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHSI", "relevance_score": "0.066199", "ticker_sentiment_score": "0.024199", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKA", "relevance_score": "0.044161", "ticker_sentiment_score": "0.033208", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.044161", "ticker_sentiment_score": "0.050932", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTPI", "relevance_score": "0.066199", "ticker_sentiment_score": "-0.053331", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBIO", "relevance_score": "0.066199", "ticker_sentiment_score": "0.003275", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.044161", "ticker_sentiment_score": "0.003529", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.044161", "ticker_sentiment_score": "0.00211", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQDA", "relevance_score": "0.066199", "ticker_sentiment_score": "-0.013802", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVDL", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.004274", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOD", "relevance_score": "0.044161", "ticker_sentiment_score": "0.017916", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.044161", "ticker_sentiment_score": "0.000774", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHAT", "relevance_score": "0.044161", "ticker_sentiment_score": "0.004946", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRC", "relevance_score": "0.066199", "ticker_sentiment_score": "0.001626", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISIG", "relevance_score": "0.044161", "ticker_sentiment_score": "0.003151", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.066199", "ticker_sentiment_score": "0.030555", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZUN", "relevance_score": "0.044161", "ticker_sentiment_score": "0.06939", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUP", "relevance_score": "0.044161", "ticker_sentiment_score": "0.00429", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSM", "relevance_score": "0.044161", "ticker_sentiment_score": "0.009435", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.066199", "ticker_sentiment_score": "0.020903", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOV", "relevance_score": "0.044161", "ticker_sentiment_score": "0.022355", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.066199", "ticker_sentiment_score": "0.006489", "ticker_sentiment_label": "Neutral"}, {"ticker": "VQS", "relevance_score": "0.044161", "ticker_sentiment_score": "0.006713", "ticker_sentiment_label": "Neutral"}, {"ticker": "APCX", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.000991", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSDT", "relevance_score": "0.044161", "ticker_sentiment_score": "-0.026089", "ticker_sentiment_label": "Neutral"}, {"ticker": "PROF", "relevance_score": "0.044161", "ticker_sentiment_score": "0.046776", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:IOP", "relevance_score": "0.022089", "ticker_sentiment_score": "0.005685", "ticker_sentiment_label": "Neutral"}]}, {"title": "61 Stocks Moving In Thursday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/05/27423710/61-stocks-moving-in-thursdays-mid-day-session", "time_published": "20220526T161028", "authors": ["Lisa Levin"], "summary": "Gainers Healthcare Triangle, Inc. ( NASDAQ: HCTI ) shares gained 46.6% to $0.9824. Healthcare Triangle recently posted a Q1 loss of $0.06 per share. Planet Green Holdings Corp. ( NYSE: PLAG ) rose 44.6% to $0.6698. Planet Green recently reported a $4 million offering. SciSparc Ltd. ( NASDAQ: S", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/26/mid-day_movers_image.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.999998"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.025233, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DG", "relevance_score": "0.064692", "ticker_sentiment_score": "0.016371", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRA", "relevance_score": "0.064692", "ticker_sentiment_score": "0.0001", "ticker_sentiment_label": "Neutral"}, {"ticker": "VGFC", "relevance_score": "0.064692", "ticker_sentiment_score": "0.824408", "ticker_sentiment_label": "Bullish"}, {"ticker": "KHC", "relevance_score": "0.064692", "ticker_sentiment_score": "-0.012905", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPN", "relevance_score": "0.064692", "ticker_sentiment_score": "0.0019", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.096906", "ticker_sentiment_score": "0.002425", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.064692", "ticker_sentiment_score": "0.004003", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCTI", "relevance_score": "0.096906", "ticker_sentiment_score": "-0.008888", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.064692", "ticker_sentiment_score": "0.000796", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBW", "relevance_score": "0.064692", "ticker_sentiment_score": "0.057193", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.096906", "ticker_sentiment_score": "-0.034342", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.064692", "ticker_sentiment_score": "0.000174", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSAT", "relevance_score": "0.064692", "ticker_sentiment_score": "-7.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYDEV", "relevance_score": "0.032373", "ticker_sentiment_score": "-0.001733", "ticker_sentiment_label": "Neutral"}, {"ticker": "QK", "relevance_score": "0.064692", "ticker_sentiment_score": "0.000501", "ticker_sentiment_label": "Neutral"}, {"ticker": "BABA", "relevance_score": "0.064692", "ticker_sentiment_score": "0.036149", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEAT", "relevance_score": "0.064692", "ticker_sentiment_score": "0.012697", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTC", "relevance_score": "0.064692", "ticker_sentiment_score": "-0.040638", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.096906", "ticker_sentiment_score": "-0.021385", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.064692", "ticker_sentiment_score": "-0.033154", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLTR", "relevance_score": "0.064692", "ticker_sentiment_score": "0.012412", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.064692", "ticker_sentiment_score": "0.001546", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.064692", "ticker_sentiment_score": "0.000757", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.064692", "ticker_sentiment_score": "0.003935", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.064692", "ticker_sentiment_score": "0.000894", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.064692", "ticker_sentiment_score": "0.020917", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIG", "relevance_score": "0.064692", "ticker_sentiment_score": "0.000816", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.064692", "ticker_sentiment_score": "-0.000187", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.064692", "ticker_sentiment_score": "0.002094", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTCW", "relevance_score": "0.064692", "ticker_sentiment_score": "-0.040638", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIMI", "relevance_score": "0.064692", "ticker_sentiment_score": "0.000553", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.064692", "ticker_sentiment_score": "0.00496", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIG", "relevance_score": "0.096906", "ticker_sentiment_score": "-0.001733", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.064692", "ticker_sentiment_score": "-0.001033", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRA", "relevance_score": "0.064692", "ticker_sentiment_score": "0.002632", "ticker_sentiment_label": "Neutral"}, {"ticker": "M", "relevance_score": "0.032373", "ticker_sentiment_score": "0.0151", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNET", "relevance_score": "0.096906", "ticker_sentiment_score": "0.007217", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.096906", "ticker_sentiment_score": "-0.007266", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.096906", "ticker_sentiment_score": "0.007315", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHSI", "relevance_score": "0.096906", "ticker_sentiment_score": "0.020917", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKA", "relevance_score": "0.064692", "ticker_sentiment_score": "0.001513", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.064692", "ticker_sentiment_score": "0.078201", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.064692", "ticker_sentiment_score": "0.001216", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQDA", "relevance_score": "0.096906", "ticker_sentiment_score": "-0.017416", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVDL", "relevance_score": "0.064692", "ticker_sentiment_score": "9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOD", "relevance_score": "0.064692", "ticker_sentiment_score": "0.01482", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.064692", "ticker_sentiment_score": "0.000137", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGE", "relevance_score": "0.064692", "ticker_sentiment_score": "0.001742", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHAT", "relevance_score": "0.064692", "ticker_sentiment_score": "0.000691", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRC", "relevance_score": "0.096906", "ticker_sentiment_score": "0.000419", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.064692", "ticker_sentiment_score": "0.001068", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.096906", "ticker_sentiment_score": "0.044315", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZUN", "relevance_score": "0.064692", "ticker_sentiment_score": "0.003773", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUP", "relevance_score": "0.064692", "ticker_sentiment_score": "0.002926", "ticker_sentiment_label": "Neutral"}, {"ticker": "TC", "relevance_score": "0.096906", "ticker_sentiment_score": "0.00093", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSM", "relevance_score": "0.064692", "ticker_sentiment_score": "0.004804", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.096906", "ticker_sentiment_score": "0.009185", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOV", "relevance_score": "0.064692", "ticker_sentiment_score": "0.007711", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.096906", "ticker_sentiment_score": "0.006887", "ticker_sentiment_label": "Neutral"}, {"ticker": "VQS", "relevance_score": "0.064692", "ticker_sentiment_score": "0.003888", "ticker_sentiment_label": "Neutral"}, {"ticker": "APCX", "relevance_score": "0.064692", "ticker_sentiment_score": "3.7e-05", "ticker_sentiment_label": "Neutral"}]}, {"title": "66 Biggest Movers From Friday", "url": "https://www.benzinga.com/news/22/05/27341379/66-biggest-movers-from-friday", "time_published": "20220523T075758", "authors": ["Lisa Levin"], "summary": "Gainers GeoVax Labs, Inc. ( NASDAQ: GOVX ) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year. Leju Holdings Limited ( NYSE: LEJU ) shares jumped 53.4% to close at $4.85 on Friday. SIGA Technologies, Inc. ( NASDAQ: SIG", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/23/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.99737"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.04121, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DE", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.000467", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGC", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.001785", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002699", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002726", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.081635", "ticker_sentiment_score": "0.003282", "ticker_sentiment_label": "Neutral"}, {"ticker": "LITM", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.201757", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SIGA", "relevance_score": "0.081635", "ticker_sentiment_score": "0.072853", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.000208", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.054477", "ticker_sentiment_score": "0.001886", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.000386", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.081635", "ticker_sentiment_score": "-0.090646", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.077138", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.054477", "ticker_sentiment_score": "0.00371", "ticker_sentiment_label": "Neutral"}, {"ticker": "JWN", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.016167", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.081635", "ticker_sentiment_score": "0.036341", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBT", "relevance_score": "0.054477", "ticker_sentiment_score": "0.011199", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.054477", "ticker_sentiment_score": "0.006625", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.081635", "ticker_sentiment_score": "0.007477", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNYA", "relevance_score": "0.081635", "ticker_sentiment_score": "0.008831", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEJU", "relevance_score": "0.054477", "ticker_sentiment_score": "0.006051", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEDU", "relevance_score": "0.054477", "ticker_sentiment_score": "0.001617", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.091931", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.054477", "ticker_sentiment_score": "0.00512", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002313", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.081635", "ticker_sentiment_score": "0.033094", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTX", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.674532", "ticker_sentiment_label": "Bearish"}, {"ticker": "EQOS", "relevance_score": "0.081635", "ticker_sentiment_score": "0.006132", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLPT", "relevance_score": "0.081635", "ticker_sentiment_score": "0.030315", "ticker_sentiment_label": "Neutral"}, {"ticker": "DECK", "relevance_score": "0.054477", "ticker_sentiment_score": "0.072434", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.054477", "ticker_sentiment_score": "0.006588", "ticker_sentiment_label": "Neutral"}, {"ticker": "VS", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002585", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.054477", "ticker_sentiment_score": "0.004053", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.009305", "ticker_sentiment_label": "Neutral"}, {"ticker": "BJ", "relevance_score": "0.081635", "ticker_sentiment_score": "0.070249", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTC", "relevance_score": "0.081635", "ticker_sentiment_score": "0.01795", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.027254", "ticker_sentiment_score": "-0.000684", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOMZ", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.179773", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DTSS", "relevance_score": "0.081635", "ticker_sentiment_score": "-0.045237", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTG", "relevance_score": "0.054477", "ticker_sentiment_score": "0.008614", "ticker_sentiment_label": "Neutral"}, {"ticker": "BORR", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.02404", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTS", "relevance_score": "0.054477", "ticker_sentiment_score": "0.006469", "ticker_sentiment_label": "Neutral"}, {"ticker": "BURL", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.36248", "ticker_sentiment_label": "Bearish"}, {"ticker": "INDP", "relevance_score": "0.081635", "ticker_sentiment_score": "0.005792", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.081635", "ticker_sentiment_score": "0.002553", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.054477", "ticker_sentiment_score": "0.003417", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.027254", "ticker_sentiment_score": "0.033094", "ticker_sentiment_label": "Neutral"}, {"ticker": "SJ", "relevance_score": "0.054477", "ticker_sentiment_score": "0.000439", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.054477", "ticker_sentiment_score": "0.01758", "ticker_sentiment_label": "Neutral"}, {"ticker": "NURO", "relevance_score": "0.081635", "ticker_sentiment_score": "0.01095", "ticker_sentiment_label": "Neutral"}, {"ticker": "XCUR", "relevance_score": "0.081635", "ticker_sentiment_score": "0.001106", "ticker_sentiment_label": "Neutral"}, {"ticker": "DERM", "relevance_score": "0.054477", "ticker_sentiment_score": "0.003793", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXH", "relevance_score": "0.054477", "ticker_sentiment_score": "0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHTX", "relevance_score": "0.081635", "ticker_sentiment_score": "0.007777", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.081635", "ticker_sentiment_score": "0.000162", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSS", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.065782", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.054477", "ticker_sentiment_score": "0.096204", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002693", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELZ", "relevance_score": "0.081635", "ticker_sentiment_score": "0.001294", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRN", "relevance_score": "0.081635", "ticker_sentiment_score": "-0.009305", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROST", "relevance_score": "0.081635", "ticker_sentiment_score": "-0.451973", "ticker_sentiment_label": "Bearish"}, {"ticker": "APLD", "relevance_score": "0.054477", "ticker_sentiment_score": "0.00128", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVET", "relevance_score": "0.081635", "ticker_sentiment_score": "0.002682", "ticker_sentiment_label": "Neutral"}]}, {"title": "12 Health Care Stocks Moving In Friday's Intraday Session", "url": "https://www.benzinga.com/trading-ideas/movers/22/05/27329608/12-health-care-stocks-moving-in-fridays-intraday-session", "time_published": "20220520T180236", "authors": ["Benzinga Insights"], "summary": "Gainers Immix Biopharma ( NASDAQ:IMMX ) shares increased by 52.1% to $2.48 during Friday's regular session. The current volume of 88.9 million shares is 47830.9% of Immix Biopharma's average full-day volume over the last 100 days ( last updated at 13:30 EST ) . The market value of their outstandi", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_9141.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}], "overall_sentiment_score": -0.006473, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NURO", "relevance_score": "0.141351", "ticker_sentiment_score": "0.000654", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.141351", "ticker_sentiment_score": "0.000704", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.141351", "ticker_sentiment_score": "0.001485", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.141351", "ticker_sentiment_score": "0.000411", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.21064", "ticker_sentiment_score": "0.001207", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.141351", "ticker_sentiment_score": "-0.000249", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.141351", "ticker_sentiment_score": "0.001015", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.141351", "ticker_sentiment_score": "0.006868", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.141351", "ticker_sentiment_score": "0.000974", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.141351", "ticker_sentiment_score": "0.008388", "ticker_sentiment_label": "Neutral"}]}, {"title": "ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug", "url": "https://www.benzinga.com/general/biotech/22/05/27322979/immixbios-lead-candidate-shows-improved-survival-over-fda-approved-soft-tissue-cancer-drug", "time_published": "20220520T141933", "authors": ["Vandana Singh"], "summary": "Immix Biopharma Inc ( NASDAQ: IMMX ) announced positive interim data from an animal study in Soft Tissue Sarcoma ( STS ) . STS is a broad term for cancers that start in soft tissues ( muscle, tendons, fat, lymph and blood vessels, and nerves ) . After one treatment cycle, ImmixBio's lead candida", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/20/aapharma_5.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.029853, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.491566", "ticker_sentiment_score": "0.055998", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.34068", "ticker_sentiment_score": "-0.000583", "ticker_sentiment_label": "Neutral"}]}, {"title": "ImmixBio IMX-110 Demonstrated Improved Survival Over U.S. Food and Drug Administration Approved Drug Trabectedin  ( sold as YONDELIS \u00ae by Janssen, a Johnson & Johnson Company )  in Connective Tissue Cancer Soft Tissue Sarcoma Mice Study", "url": "https://www.benzinga.com/pressreleases/22/05/g27321109/immixbio-imx-110-demonstrated-improved-survival-over-u-s-food-and-drug-administration-approved-dru", "time_published": "20220520T124735", "authors": ["Globe Newswire"], "summary": "One cycle of IMX-110 produced 75% survival vs. 0% survival for Trabectedin ( sold as YONDELIS \u00ae by Janssen, a Johnson & Johnson Company, a U.S. FDA approved drug ) In a connective tissue cancer Soft Tissue Sarcoma ( STS ) mice study, IMX-110 was compared against approved drugs IMX-110 is in clin", "banner_image": "https://ml.globenewswire.com/media/b46d5687-65de-44df-81d5-e36f2665d8e7/small/immix-logonew-gray-png.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.017503, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.225028", "ticker_sentiment_score": "0.032897", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.09104", "ticker_sentiment_score": "0.035401", "ticker_sentiment_label": "Neutral"}]}, {"title": "ImmixBio IMX-110 Demonstrated Improved Survival Over U.S. Food and Drug Administration Approved Drug Trabectedin  ( sold as YONDELIS \u00ae by Janssen, a Johnson & Johnson Company )  in Connective Tissue Cancer Soft Tissue Sarcoma Mice Study", "url": "https://www.globenewswire.com/news-release/2022/05/20/2447697/0/en/ImmixBio-IMX-110-Demonstrated-Improved-Survival-Over-U-S-Food-and-Drug-Administration-Approved-Drug-Trabectedin-sold-as-YONDELIS-by-Janssen-a-Johnson-Johnson-Company-in-Connective-.html", "time_published": "20220520T124700", "authors": ["Immix Biopharma", "Inc."], "summary": "A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/38fdaa24-38ff-482c-8b72-63baa730a3a2", "banner_image": "https://ml.globenewswire.com/Resource/Download/38fdaa24-38ff-482c-8b72-63baa730a3a2?size=2", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.027543, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.189039", "ticker_sentiment_score": "0.030367", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.095195", "ticker_sentiment_score": "0.021207", "ticker_sentiment_label": "Neutral"}]}, {"title": "71 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/05/27318002/71-biggest-movers-from-yesterday", "time_published": "20220520T082731", "authors": ["Lisa Levin"], "summary": "Gainers NeuroMetrix, Inc. ( NASDAQ: NURO ) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia. VivoPower International PLC ( NASDAQ:", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/20/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.013704, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEGY", "relevance_score": "0.055946", "ticker_sentiment_score": "0.021826", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.055946", "ticker_sentiment_score": "0.003154", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYAD", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001977", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.02799", "ticker_sentiment_score": "0.012444", "ticker_sentiment_label": "Neutral"}, {"ticker": "UA", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.066954", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBWI", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002431", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNOX", "relevance_score": "0.055946", "ticker_sentiment_score": "0.023839", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIEW", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001115", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPOP", "relevance_score": "0.055946", "ticker_sentiment_score": "0.011712", "ticker_sentiment_label": "Neutral"}, {"ticker": "LITM", "relevance_score": "0.055946", "ticker_sentiment_score": "0.067598", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.055946", "ticker_sentiment_score": "0.010507", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.152492", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BILL", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002847", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.308477", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NOVN", "relevance_score": "0.083833", "ticker_sentiment_score": "0.004658", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.055946", "ticker_sentiment_score": "0.009302", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.055946", "ticker_sentiment_score": "0.008796", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOG", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.047485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.055946", "ticker_sentiment_score": "0.006289", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNYA", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002289", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.02799", "ticker_sentiment_score": "-0.066954", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRTS", "relevance_score": "0.055946", "ticker_sentiment_score": "0.000804", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLLS", "relevance_score": "0.055946", "ticker_sentiment_score": "0.006819", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.083833", "ticker_sentiment_score": "0.044934", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.055946", "ticker_sentiment_score": "0.011779", "ticker_sentiment_label": "Neutral"}, {"ticker": "SXTC", "relevance_score": "0.083833", "ticker_sentiment_score": "0.012444", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGI", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.287624", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SNPS", "relevance_score": "0.055946", "ticker_sentiment_score": "0.024499", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNRO", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001917", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEAL", "relevance_score": "0.055946", "ticker_sentiment_score": "0.080252", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIG", "relevance_score": "0.055946", "ticker_sentiment_score": "0.00781", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.055946", "ticker_sentiment_score": "0.030687", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.104888", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFI", "relevance_score": "0.083833", "ticker_sentiment_score": "0.009987", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.055946", "ticker_sentiment_score": "0.004885", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDNY", "relevance_score": "0.055946", "ticker_sentiment_score": "0.003658", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGEN", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.018968", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTC", "relevance_score": "0.083833", "ticker_sentiment_score": "0.026282", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.02799", "ticker_sentiment_score": "0.000584", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFH", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002076", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRX", "relevance_score": "0.055946", "ticker_sentiment_score": "-0.012885", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDP", "relevance_score": "0.083833", "ticker_sentiment_score": "0.004275", "ticker_sentiment_label": "Neutral"}, {"ticker": "SG", "relevance_score": "0.055946", "ticker_sentiment_score": "0.006098", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.055946", "ticker_sentiment_score": "0.008839", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.055946", "ticker_sentiment_score": "0.006237", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.083833", "ticker_sentiment_score": "0.035774", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.055946", "ticker_sentiment_score": "0.007085", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUUD", "relevance_score": "0.055946", "ticker_sentiment_score": "-0.003374", "ticker_sentiment_label": "Neutral"}, {"ticker": "NURO", "relevance_score": "0.055946", "ticker_sentiment_score": "0.015032", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAF", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001238", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.055946", "ticker_sentiment_score": "0.000475", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAC", "relevance_score": "0.083833", "ticker_sentiment_score": "0.003082", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.006915", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNFR", "relevance_score": "0.055946", "ticker_sentiment_score": "-0.034219", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001914", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVPR", "relevance_score": "0.055946", "ticker_sentiment_score": "0.005911", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAB", "relevance_score": "0.055946", "ticker_sentiment_score": "0.000383", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.055946", "ticker_sentiment_score": "0.003369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.083833", "ticker_sentiment_score": "0.003382", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRA", "relevance_score": "0.055946", "ticker_sentiment_score": "0.000614", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002359", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRKA", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002531", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.083833", "ticker_sentiment_score": "0.006608", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLD", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002653", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRX", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.024318", "ticker_sentiment_label": "Neutral"}, {"ticker": "APCX", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001122", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.02799", "ticker_sentiment_score": "0.023839", "ticker_sentiment_label": "Neutral"}]}, {"title": "12 Health Care Stocks Moving In Monday's Pre-Market Session", "url": "https://www.benzinga.com/trading-ideas/movers/22/05/27217184/12-health-care-stocks-moving-in-mondays-pre-market-session", "time_published": "20220516T121648", "authors": ["Benzinga Insights"], "summary": "Gainers Athenex ( NASDAQ:ATNX ) shares increased by 30.5% to $0.62 during Monday's pre-market session. The market value of their outstanding shares is at $69.1 million. As per the press release, Q1 earnings came out 4 days ago. Verastem ( NASDAQ:VSTM ) stock rose 25.0% to $1.35. The company's ma", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8664.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.005967, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATNX", "relevance_score": "0.237551", "ticker_sentiment_score": "0.007507", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.237551", "ticker_sentiment_score": "0.003548", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.237551", "ticker_sentiment_score": "0.00191", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.237551", "ticker_sentiment_score": "0.000519", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDTX", "relevance_score": "0.237551", "ticker_sentiment_score": "0.022496", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.237551", "ticker_sentiment_score": "-0.000395", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.237551", "ticker_sentiment_score": "0.002454", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.237551", "ticker_sentiment_score": "0.003241", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSTM", "relevance_score": "0.237551", "ticker_sentiment_score": "0.008247", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.237551", "ticker_sentiment_score": "0.007559", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRGA", "relevance_score": "0.237551", "ticker_sentiment_score": "0.009778", "ticker_sentiment_label": "Neutral"}]}, {"title": "30 Stocks Moving in Monday's Pre-Market Session", "url": "https://www.benzinga.com/news/22/05/27214770/30-stocks-moving-in-mondays-pre-market-session", "time_published": "20220516T105756", "authors": ["Lisa Levin"], "summary": "Gainers AgriFORCE Growing Systems Ltd. ( NASDAQ: AGRI ) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on Friday. ShiftPixy, Inc. ( NASDAQ: PIXY ) rose 21.5% to $0.6198 in pre-market trading after jumping 155% on Friday. Calyxt, Inc. ( NASDAQ: CLXT ) shares rose 21.4% to $", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/16/premkt_movers.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.023403, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALNA", "relevance_score": "0.11818", "ticker_sentiment_score": "0.000653", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.11818", "ticker_sentiment_score": "0.00294", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.11818", "ticker_sentiment_score": "0.000528", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNDL", "relevance_score": "0.176459", "ticker_sentiment_score": "0.00278", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.11818", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIX", "relevance_score": "0.11818", "ticker_sentiment_score": "0.0005", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.11818", "ticker_sentiment_score": "0.000367", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAGX", "relevance_score": "0.176459", "ticker_sentiment_score": "0.00218", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.11818", "ticker_sentiment_score": "0.000896", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.176459", "ticker_sentiment_score": "-0.000487", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVE", "relevance_score": "0.11818", "ticker_sentiment_score": "-0.018931", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.176459", "ticker_sentiment_score": "0.024308", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.11818", "ticker_sentiment_score": "0.002427", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTER", "relevance_score": "0.176459", "ticker_sentiment_score": "-0.227675", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AVPT", "relevance_score": "0.176459", "ticker_sentiment_score": "-0.003172", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.11818", "ticker_sentiment_score": "0.001582", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.176459", "ticker_sentiment_score": "0.0078", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.176459", "ticker_sentiment_score": "0.000408", "ticker_sentiment_label": "Neutral"}, {"ticker": "UXIN", "relevance_score": "0.176459", "ticker_sentiment_score": "0.000719", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.11818", "ticker_sentiment_score": "-0.129751", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOL", "relevance_score": "0.11818", "ticker_sentiment_score": "0.000305", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.176459", "ticker_sentiment_score": "-0.003338", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERB", "relevance_score": "0.11818", "ticker_sentiment_score": "0.00039", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOEV", "relevance_score": "0.11818", "ticker_sentiment_score": "0.003322", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.11818", "ticker_sentiment_score": "0.000721", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.11818", "ticker_sentiment_score": "0.001145", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANPC", "relevance_score": "0.11818", "ticker_sentiment_score": "0.001377", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.11818", "ticker_sentiment_score": "0.000329", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBRX", "relevance_score": "0.176459", "ticker_sentiment_score": "-0.004128", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/markets/options/22/04/26844275/52-weeks-high-and-low-article", "time_published": "20220427T184104", "authors": ["Benzinga Insights"], "summary": "Wednesday's session saw 784 companies set new 52-week lows.\nKey Facts About Today's 52-Week Lows:\nMeta Platforms  ( NASDAQ:FB )  was the biggest company by market cap to set a new 52-week low.\nNova Lifestyle  ( NASDAQ:NVFY )  was the smallest, in terms of market cap, to set a new 52-week low.\nMolecu", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7415.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.024509, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SSNT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012617", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.003478", "ticker_sentiment_score": "0.003342", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008877", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006223", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.021661", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014715", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACCO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.301882", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OLMA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003767", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.071126", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000191", "ticker_sentiment_label": "Neutral"}, {"ticker": "EZFL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008227", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOLD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.018875", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.022985", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013583", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001136", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOTV", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017693", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003147", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.58381", "ticker_sentiment_label": "Bearish"}, {"ticker": "HESG", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.00143", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001921", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOFT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.031163", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000296", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00588", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001682", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001729", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCAB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007262", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015432", "ticker_sentiment_label": "Neutral"}, {"ticker": "BB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.026903", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016763", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVEC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009395", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001861", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014376", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSSS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014383", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001933", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013438", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003147", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKSI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.0037", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001666", "ticker_sentiment_label": "Neutral"}, {"ticker": "HROW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014681", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003278", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.023457", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.0031", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.019862", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004911", "ticker_sentiment_label": "Neutral"}, {"ticker": "THO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000745", "ticker_sentiment_label": "Neutral"}, {"ticker": "TURN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002435", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.010434", "ticker_sentiment_score": "-0.004274", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.255918", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UDMY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.03117", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001731", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009732", "ticker_sentiment_label": "Neutral"}, {"ticker": "THR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.058424", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005755", "ticker_sentiment_label": "Neutral"}, {"ticker": "CG", "relevance_score": "0.006956", "ticker_sentiment_score": "6e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016143", "ticker_sentiment_label": "Neutral"}, {"ticker": "VISL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000427", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCYO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008727", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.018398", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008787", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017364", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZNC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001128", "ticker_sentiment_label": "Neutral"}, {"ticker": "JVA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010822", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002926", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001709", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.347475", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "STRO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.302553", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CVET", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001024", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.011476", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004284", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.027416", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.041488", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014789", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007839", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLGY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004665", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007459", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000842", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012938", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADV", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009804", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYMT", "relevance_score": "0.006956", "ticker_sentiment_score": "-3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.011807", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.117271", "ticker_sentiment_label": "Neutral"}, {"ticker": "EB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000242", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.232673", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LABP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012649", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007016", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000682", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004064", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000564", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000332", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.013321", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006026", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006966", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.018373", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.021739", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.034726", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.100714", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001337", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00081", "ticker_sentiment_label": "Neutral"}, {"ticker": "FB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.115496", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004041", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014346", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVFY", "relevance_score": "0.013912", "ticker_sentiment_score": "0.068673", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004443", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010667", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006617", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.04434", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010807", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002565", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005508", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.024343", "ticker_sentiment_score": "-0.086459", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNGX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.057761", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000199", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000419", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000374", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001824", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBLU", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015993", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXFY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000776", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.037797", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003479", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005634", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002598", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.02811", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.023724", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003729", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXTI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008298", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013152", "ticker_sentiment_label": "Neutral"}, {"ticker": "USNA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00143", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.389457", "ticker_sentiment_label": "Bearish"}, {"ticker": "ISRG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.053483", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012244", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTRS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001009", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.068341", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001545", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLIO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001458", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001002", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013186", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGHT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004241", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.204649", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.031021", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.272985", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCEL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003392", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNST", "relevance_score": "0.006956", "ticker_sentiment_score": "0.019695", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000126", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.039875", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008709", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.006956", "ticker_sentiment_score": "-4.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNDA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00522", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFBC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013615", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017205", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005309", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010078", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPAA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015124", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSV", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.59339", "ticker_sentiment_label": "Bearish"}, {"ticker": "AVRO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000253", "ticker_sentiment_label": "Neutral"}, {"ticker": "YTEN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.031949", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000982", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKOH", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004094", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010062", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005478", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYNT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012065", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGMS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017789", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.408704", "ticker_sentiment_label": "Bearish"}, {"ticker": "IBRX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003091", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.048664", "ticker_sentiment_score": "-0.003242", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001521", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014015", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009848", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000278", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.071126", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00431", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.032365", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFMS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009368", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01034", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOXF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.279613", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACMR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.0291", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015741", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001151", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.383431", "ticker_sentiment_label": "Bearish"}, {"ticker": "CEMI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007208", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001798", "ticker_sentiment_label": "Neutral"}, {"ticker": "KN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002199", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.038845", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002288", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012717", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPLD", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003671", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001943", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.358825", "ticker_sentiment_label": "Bearish"}, {"ticker": "ADPT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.022179", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000606", "ticker_sentiment_label": "Neutral"}, {"ticker": "TARA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.543695", "ticker_sentiment_label": "Bearish"}, {"ticker": "USX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007008", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.321695", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NRDY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008949", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTEX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009198", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000452", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000999", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014325", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPER", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010105", "ticker_sentiment_label": "Neutral"}, {"ticker": "KPLT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.023773", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIFY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.189098", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DTIL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003697", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.018232", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.003478", "ticker_sentiment_score": "0.000535", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.058218", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDLS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000815", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007873", "ticker_sentiment_label": "Neutral"}, {"ticker": "MG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007751", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.013785", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001193", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.038126", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005311", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011551", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002839", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAKE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.024648", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00022", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.025518", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005186", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCI", "relevance_score": "0.010434", "ticker_sentiment_score": "-0.00874", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCFC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010297", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003112", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001427", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006295", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002959", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFUS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00168", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNST", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013696", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009879", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQZ", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.021697", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMCX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003485", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.071927", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002823", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005056", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001901", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.0002", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000236", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.011154", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003052", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003067", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.015428", "ticker_sentiment_label": "Neutral"}, {"ticker": "HEAR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000837", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000661", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006936", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006674", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000871", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTBP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001863", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000446", "ticker_sentiment_label": "Neutral"}, {"ticker": "DELL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.053044", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYXH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004037", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003136", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.0007", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011451", "ticker_sentiment_label": "Neutral"}, {"ticker": "PMD", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005098", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLDR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005724", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013666", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014051", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002143", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009119", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCOV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009176", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.060278", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009026", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008106", "ticker_sentiment_label": "Neutral"}, {"ticker": "FXLV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000185", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010642", "ticker_sentiment_label": "Neutral"}, {"ticker": "APO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013092", "ticker_sentiment_label": "Neutral"}, {"ticker": "APP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000808", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLWS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.029896", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATUS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002683", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004771", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007665", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01639", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRIO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.023908", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005197", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001537", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01044", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.016234", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012615", "ticker_sentiment_label": "Neutral"}, {"ticker": "DENN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.028418", "ticker_sentiment_label": "Neutral"}, {"ticker": "NERV", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.18013", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MLAB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.033966", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.001837", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAND", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.067387", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010293", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSQR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015376", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.03741", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001805", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCMI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.389493", "ticker_sentiment_label": "Bearish"}, {"ticker": "CURI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003047", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAII", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.172552", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PACK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014442", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006059", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.024115", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001381", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000101", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPFI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011271", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000875", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017063", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009245", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00412", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010282", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003854", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002329", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSRR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.024285", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.037236", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.022452", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003245", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005093", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.446202", "ticker_sentiment_label": "Bearish"}, {"ticker": "PPBI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004512", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004505", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.02625", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002475", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010512", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTEC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005696", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003771", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006601", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTHM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001947", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017597", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008233", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKNA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.01199", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTES", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006794", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003267", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLFC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001133", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014593", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002758", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAAS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.525885", "ticker_sentiment_label": "Bearish"}, {"ticker": "SYNH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002169", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.020881", "ticker_sentiment_label": "Neutral"}, {"ticker": "TILE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.052336", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012392", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014251", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.182314", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HBI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005759", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.006956", "ticker_sentiment_score": "0.02293", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRON", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012079", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008347", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.014125", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006544", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003326", "ticker_sentiment_label": "Neutral"}, {"ticker": "UIHC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008093", "ticker_sentiment_label": "Neutral"}, {"ticker": "RWT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005272", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004262", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004065", "ticker_sentiment_label": "Neutral"}, {"ticker": "LASR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00727", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008439", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.061226", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011625", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010839", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004492", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001129", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBIO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003864", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009463", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017931", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.027563", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.282746", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GSHD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001756", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013015", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHCO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.366969", "ticker_sentiment_label": "Bearish"}, {"ticker": "MRTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000817", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000642", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBUU", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00097", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.006956", "ticker_sentiment_score": "0.032139", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00404", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.001264", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOCS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008088", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01631", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004698", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001047", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00432", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00859", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006439", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.024224", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.060555", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.041404", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016703", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001744", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.027874", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIGL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003153", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUWE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00711", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004143", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001699", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONEW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.025066", "ticker_sentiment_label": "Neutral"}, {"ticker": "XL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.019773", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009158", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSVB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000462", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.001264", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015613", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004247", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00132", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.030263", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFTR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.020452", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003641", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.015243", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDSA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016808", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.050771", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.031295", "ticker_sentiment_score": "0.002099", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.021551", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.035314", "ticker_sentiment_label": "Neutral"}, {"ticker": "FERG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00239", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPW", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001576", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.048426", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.020884", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005937", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000906", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBMT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001385", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.0384", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002331", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001587", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.070554", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006335", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014614", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTXR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009084", "ticker_sentiment_label": "Neutral"}, {"ticker": "MATW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00469", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.001566", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003614", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006117", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHPW", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008555", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOMD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.084826", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010083", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.021997", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBF", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004728", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006191", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002459", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDUC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.015428", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004112", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBNC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.035798", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001767", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOXX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007798", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFCG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009093", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003381", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.031259", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDNT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008022", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMMB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004944", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.033572", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004164", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGCP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000828", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001006", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000284", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004438", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRLN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007664", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005953", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.02371", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001331", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008584", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000723", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLBY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004238", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLCE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003271", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00726", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNNE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005717", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBRA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001386", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000159", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003243", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011591", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008696", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.006956", "ticker_sentiment_score": "0.028413", "ticker_sentiment_label": "Neutral"}, {"ticker": "UEIC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006108", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001284", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTZ", "relevance_score": "0.006956", "ticker_sentiment_score": "0.011944", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNGR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001894", "ticker_sentiment_label": "Neutral"}, {"ticker": "VFF", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002897", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.10209", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.013315", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.025077", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000432", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENIA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000742", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENIC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017113", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003479", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.426632", "ticker_sentiment_label": "Bearish"}, {"ticker": "BEAM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.04627", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005071", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006057", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLTR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001037", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014522", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001419", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012444", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01839", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.005276", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014151", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.017232", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001563", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015017", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.020872", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005609", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003924", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01495", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016176", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002752", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGIO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010525", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFST", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001944", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.071345", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.02039", "ticker_sentiment_label": "Neutral"}, {"ticker": "XLO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012466", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002422", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009716", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002471", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003714", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDIMF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.00185", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGTY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003869", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000901", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETWO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.374436", "ticker_sentiment_label": "Bearish"}, {"ticker": "CMPR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.034053", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009777", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYLT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000769", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015552", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012043", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.319319", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCZ", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.020073", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Tuesday", "url": "https://www.benzinga.com/markets/options/22/04/26818122/52-weeks-high-and-low-article", "time_published": "20220426T174457", "authors": ["Benzinga Insights"], "summary": "During Tuesday, 581 stocks hit new 52-week lows.\nInteresting Highlights From Today's 52-Week Lows\nMeta Platforms  ( NASDAQ:FB )  was the biggest company on a market cap basis to set a new 52-week low.\nThe smallest company by market cap to set a new 52-week low was AnPac Bio-Medical Science  ( NASDAQ", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7317.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.030962, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MEDP", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002294", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.009107", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGLE", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006202", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006933", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDE", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002074", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSBF", "relevance_score": "0.00928", "ticker_sentiment_score": "0.013711", "ticker_sentiment_label": "Neutral"}, {"ticker": "SESN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.008034", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.00928", "ticker_sentiment_score": "0.010335", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00425", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004112", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOLD", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.02714", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.014757", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.000344", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.00928", "ticker_sentiment_score": "0.013079", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001706", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQV", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002624", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.329371", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VRCA", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004606", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000683", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOFT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.000666", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000571", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAMP", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.011038", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.228816", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SOFI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002882", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.615901", "ticker_sentiment_label": "Bearish"}, {"ticker": "BCAB", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007113", "ticker_sentiment_label": "Neutral"}, {"ticker": "BB", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.013337", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLIC", "relevance_score": "0.00928", "ticker_sentiment_score": "0.000519", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.00464", "ticker_sentiment_score": "0.006807", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.00928", "ticker_sentiment_score": "0.000855", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.403302", "ticker_sentiment_label": "Bearish"}, {"ticker": "VREX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.276408", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AXON", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00787", "ticker_sentiment_label": "Neutral"}, {"ticker": "IESC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001528", "ticker_sentiment_label": "Neutral"}, {"ticker": "HROW", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002463", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.328048", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VLN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.023168", "ticker_sentiment_label": "Neutral"}, {"ticker": "TURN", "relevance_score": "0.00928", "ticker_sentiment_score": "0.018587", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.01392", "ticker_sentiment_score": "-0.004888", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.322793", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CGC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00833", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.03249", "ticker_sentiment_label": "Neutral"}, {"ticker": "WNW", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003854", "ticker_sentiment_label": "Neutral"}, {"ticker": "CG", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001599", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.010266", "ticker_sentiment_label": "Neutral"}, {"ticker": "VISL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004803", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACH", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001627", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCYO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006323", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006477", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.008281", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.00928", "ticker_sentiment_score": "0.028723", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001575", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00043", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004398", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.011667", "ticker_sentiment_label": "Neutral"}, {"ticker": "MHLD", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.50954", "ticker_sentiment_label": "Bearish"}, {"ticker": "AZTA", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004431", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.005774", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000175", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.024554", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.00928", "ticker_sentiment_score": "0.009752", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.013913", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.038112", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATIP", "relevance_score": "0.00928", "ticker_sentiment_score": "0.022246", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITRM", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00997", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.00928", "ticker_sentiment_score": "0.036946", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAY", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000401", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.020749", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLGY", "relevance_score": "0.00928", "ticker_sentiment_score": "0.034549", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00259", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCTI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004298", "ticker_sentiment_label": "Neutral"}, {"ticker": "FORA", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.009626", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.090351", "ticker_sentiment_label": "Neutral"}, {"ticker": "EB", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002673", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.008049", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003844", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEK", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.012918", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.035545", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.0148", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.010823", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANW", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.013015", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.007138", "ticker_sentiment_label": "Neutral"}, {"ticker": "FB", "relevance_score": "0.018559", "ticker_sentiment_score": "0.033895", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00074", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004418", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001374", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.00122", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENZ", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003664", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00067", "ticker_sentiment_label": "Neutral"}, {"ticker": "CION", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.006747", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRWG", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.010927", "ticker_sentiment_label": "Neutral"}, {"ticker": "GE", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.006434", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007238", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.00928", "ticker_sentiment_score": "0.010241", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.013141", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.005015", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.017024", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXTI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.015553", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.01558", "ticker_sentiment_label": "Neutral"}, {"ticker": "USNA", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.329371", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PEN", "relevance_score": "0.00928", "ticker_sentiment_score": "0.065757", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTH", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002291", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002168", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006232", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRFS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004246", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.005545", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.246001", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LOCO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.006077", "ticker_sentiment_label": "Neutral"}, {"ticker": "ODC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.009956", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.291645", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCEL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003413", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003806", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNST", "relevance_score": "0.00928", "ticker_sentiment_score": "0.014892", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002256", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSKEF", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.013907", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.29692", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CYRX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.007699", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000246", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSV", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000589", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.00928", "ticker_sentiment_score": "0.000323", "ticker_sentiment_label": "Neutral"}, {"ticker": "IR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.016912", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.004746", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.0981", "ticker_sentiment_label": "Neutral"}, {"ticker": "YTEN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.03126", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.00928", "ticker_sentiment_score": "0.008728", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.062475", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.01183", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.291201", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NGMS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007185", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOD", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.02034", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYME", "relevance_score": "0.00928", "ticker_sentiment_score": "0.015449", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.01392", "ticker_sentiment_score": "-0.098479", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000725", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.00928", "ticker_sentiment_score": "0.032724", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.023649", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.001", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOM", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00502", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESE", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003586", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOXF", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002918", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACMR", "relevance_score": "0.00928", "ticker_sentiment_score": "0.021818", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.013235", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEMI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003639", "ticker_sentiment_label": "Neutral"}, {"ticker": "JANX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003941", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUV", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.027767", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001456", "ticker_sentiment_label": "Neutral"}, {"ticker": "XYL", "relevance_score": "0.00928", "ticker_sentiment_score": "0.010113", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.427957", "ticker_sentiment_label": "Bearish"}, {"ticker": "AVTR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00695", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPLD", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004234", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBA", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.009866", "ticker_sentiment_label": "Neutral"}, {"ticker": "XFOR", "relevance_score": "0.00928", "ticker_sentiment_score": "0.009544", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00143", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.008938", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.005278", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001801", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDY", "relevance_score": "0.00928", "ticker_sentiment_score": "0.009244", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004712", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.01773", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.024534", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.006964", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004947", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALV", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002396", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOAH", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006544", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPER", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00461", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.247675", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SIFY", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006216", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001483", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.020984", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOC", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00422", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.00928", "ticker_sentiment_score": "0.005143", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.020688", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDLS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00076", "ticker_sentiment_label": "Neutral"}, {"ticker": "MG", "relevance_score": "0.00928", "ticker_sentiment_score": "0.061041", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.00928", "ticker_sentiment_score": "0.044669", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.044691", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTLT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007568", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.018553", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMMT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.025344", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007518", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004147", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGEN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003971", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFUS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.025638", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.00928", "ticker_sentiment_score": "-6.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004965", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.008049", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQZ", "relevance_score": "0.00928", "ticker_sentiment_score": "-6.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRM", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003083", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006148", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00054", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESA", "relevance_score": "0.00928", "ticker_sentiment_score": "2.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.020622", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSBW", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.238324", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ANGN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003553", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.00928", "ticker_sentiment_score": "0.000115", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.012049", "ticker_sentiment_label": "Neutral"}, {"ticker": "HEAR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.050279", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTGX", "relevance_score": "0.01392", "ticker_sentiment_score": "-0.200907", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ANGI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.008769", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.022424", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.039129", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000676", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTBP", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003847", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDMO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.018988", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.00928", "ticker_sentiment_score": "0.008099", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000147", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.012719", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003689", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMPT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.015067", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.014543", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLDR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001787", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003896", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00031", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004251", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.00928", "ticker_sentiment_score": "0.000868", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVXL", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003686", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003802", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEV", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.026419", "ticker_sentiment_label": "Neutral"}, {"ticker": "FXLV", "relevance_score": "0.00928", "ticker_sentiment_score": "0.005385", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.01076", "ticker_sentiment_label": "Neutral"}, {"ticker": "APP", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.007133", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFC", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004291", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRKN", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006498", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATUS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00891", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIASP", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.006125", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00305", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002324", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.036688", "ticker_sentiment_label": "Neutral"}, {"ticker": "NERV", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.011768", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLAB", "relevance_score": "0.00928", "ticker_sentiment_score": "0.053103", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.017302", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUP", "relevance_score": "0.00928", "ticker_sentiment_score": "0.000241", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004208", "ticker_sentiment_label": "Neutral"}, {"ticker": "REED", "relevance_score": "0.00928", "ticker_sentiment_score": "0.011331", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCMI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001621", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.268091", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RNWK", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001158", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHLD", "relevance_score": "0.00928", "ticker_sentiment_score": "0.005577", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.017205", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUBS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006104", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTE", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004729", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOPN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.05128", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.0102", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAY", "relevance_score": "0.00928", "ticker_sentiment_score": "0.005923", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONB", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002897", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002266", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.015557", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007198", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTTX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.155958", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "INTZ", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.008142", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004267", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.013101", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002322", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001161", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.264736", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FELE", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003477", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.00928", "ticker_sentiment_score": "0.005395", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002308", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.00928", "ticker_sentiment_score": "0.017312", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.01075", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLBT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.040508", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAB", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.35794", "ticker_sentiment_label": "Bearish"}, {"ticker": "GTEC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00085", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00499", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.00928", "ticker_sentiment_score": "0.008093", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.010845", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000999", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.035583", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRNC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.017656", "ticker_sentiment_label": "Neutral"}, {"ticker": "CROX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.279926", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RAAS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.017657", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNH", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00156", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.034802", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.006149", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.000872", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYD", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002372", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRON", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002716", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002709", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYH", "relevance_score": "0.00928", "ticker_sentiment_score": "0.021942", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.007287", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.005053", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.009532", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.330058", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PTLO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002986", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002261", "ticker_sentiment_label": "Neutral"}, {"ticker": "VC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00743", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00092", "ticker_sentiment_label": "Neutral"}, {"ticker": "LASR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.083485", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001074", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.012475", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001345", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004476", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.00464", "ticker_sentiment_score": "0.008227", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00056", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.00928", "ticker_sentiment_score": "0.049391", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006242", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.060055", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007529", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.006138", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.235068", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FOCS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.018819", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.021472", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOM", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00723", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.007643", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBRV", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001793", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.417336", "ticker_sentiment_label": "Bearish"}, {"ticker": "MOMO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.026915", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXG", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006049", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003702", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00429", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.114878", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007602", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.00464", "ticker_sentiment_score": "0.005053", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIGL", "relevance_score": "0.00928", "ticker_sentiment_score": "0.000963", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004348", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.005063", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.003682", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.00464", "ticker_sentiment_score": "0.007518", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.00928", "ticker_sentiment_score": "0.041238", "ticker_sentiment_label": "Neutral"}, {"ticker": "REKR", "relevance_score": "0.00928", "ticker_sentiment_score": "0.07131", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANPC", "relevance_score": "0.00928", "ticker_sentiment_score": "0.074603", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTE", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006004", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.00928", "ticker_sentiment_score": "0.008402", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.527413", "ticker_sentiment_label": "Bearish"}, {"ticker": "CDXS", "relevance_score": "0.00928", "ticker_sentiment_score": "0.000719", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.010079", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.00928", "ticker_sentiment_score": "0.068774", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002639", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDSA", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.007149", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.01392", "ticker_sentiment_score": "-0.27309", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "QTNT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.019766", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.111649", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.025319", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPW", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001532", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUZE", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.009497", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.068325", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLED", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.01435", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001597", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.325121", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CASI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.009741", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDEX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.008227", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.036357", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.009285", "ticker_sentiment_label": "Neutral"}, {"ticker": "APVO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007362", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.010414", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOMD", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.018389", "ticker_sentiment_label": "Neutral"}, {"ticker": "NATH", "relevance_score": "0.00928", "ticker_sentiment_score": "0.011605", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.089489", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCR", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.346565", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OCUP", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.041247", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPGF", "relevance_score": "0.00464", "ticker_sentiment_score": "0.002249", "ticker_sentiment_label": "Neutral"}, {"ticker": "OOMA", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.289356", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VOXX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001142", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.450796", "ticker_sentiment_label": "Bearish"}, {"ticker": "COOK", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.225605", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KOD", "relevance_score": "0.00928", "ticker_sentiment_score": "0.013609", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.00928", "ticker_sentiment_score": "0.007221", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIM", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003088", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002066", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.008815", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.005365", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004674", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZME", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001877", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.016765", "ticker_sentiment_label": "Neutral"}, {"ticker": "USAU", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.007838", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLCE", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.005438", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.00928", "ticker_sentiment_score": "0.002154", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSTK", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004068", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVCO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.006215", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.005513", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001067", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.058301", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMBL", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.006895", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMAX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002815", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIKI", "relevance_score": "0.00928", "ticker_sentiment_score": "0.008408", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.00928", "ticker_sentiment_score": "0.097518", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.011723", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.009022", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIMC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.001413", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002169", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.0051", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002385", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.00928", "ticker_sentiment_score": "0.03447", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.006269", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANVS", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.314577", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ADBE", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002545", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001203", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.474809", "ticker_sentiment_label": "Bearish"}, {"ticker": "ADCT", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.009378", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.04019", "ticker_sentiment_label": "Neutral"}, {"ticker": "VHC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.004981", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002467", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGIO", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.023026", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.00251", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTEX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003526", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.00928", "ticker_sentiment_score": "0.003027", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTV", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.014364", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001023", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETWO", "relevance_score": "0.00928", "ticker_sentiment_score": "0.019723", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAK", "relevance_score": "0.00928", "ticker_sentiment_score": "0.004283", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDAY", "relevance_score": "0.00928", "ticker_sentiment_score": "0.023312", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPR", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.002659", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOVE", "relevance_score": "0.00928", "ticker_sentiment_score": "0.042952", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.001306", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGTX", "relevance_score": "0.00928", "ticker_sentiment_score": "0.00041", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:BGN", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.026419", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.00464", "ticker_sentiment_score": "0.008093", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:SLR", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.00499", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NMR", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.010845", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:PTC", "relevance_score": "0.00928", "ticker_sentiment_score": "-0.010187", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTX", "relevance_score": "0.00464", "ticker_sentiment_score": "-0.026845", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/markets/options/22/04/26791205/52-weeks-high-and-low-article", "time_published": "20220425T160100", "authors": ["Benzinga Insights"], "summary": "On Monday, 721 companies achieved new lows for the year.\nInteresting Facts About Today's 52-Week Lows:\nMeta Platforms  ( NASDAQ:FB )  is the largest company in terms of market cap to set a new 52-week low this morning.\nThe smallest company on a market cap basis to set a new 52-week low was AnPac Bio", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7211.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.023706, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TRIP", "relevance_score": "0.004077", "ticker_sentiment_score": "-0.005404", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.009703", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004369", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.005137", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSBF", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.021759", "ticker_sentiment_label": "Neutral"}, {"ticker": "SESN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00084", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006111", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001386", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000605", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLW", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001714", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.008154", "ticker_sentiment_score": "0.008693", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.01414", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.004077", "ticker_sentiment_score": "-0.055929", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005659", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003869", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00263", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.004077", "ticker_sentiment_score": "-0.001733", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001362", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.262527", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SSNC", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006826", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001521", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005047", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.081292", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCAB", "relevance_score": "0.008154", "ticker_sentiment_score": "0.018511", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.004077", "ticker_sentiment_score": "-0.028211", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00622", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.011944", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGNC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.020602", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLUE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003963", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAY", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005384", "ticker_sentiment_label": "Neutral"}, {"ticker": "VREX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003175", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002965", "ticker_sentiment_label": "Neutral"}, {"ticker": "BL", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005627", "ticker_sentiment_label": "Neutral"}, {"ticker": "IESC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.013428", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.027127", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPO", "relevance_score": "0.008154", "ticker_sentiment_score": "0.01341", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.010406", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.022569", "ticker_sentiment_label": "Neutral"}, {"ticker": "THO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.007194", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003468", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.018362", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGC", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001202", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.008154", "ticker_sentiment_score": "0.004935", "ticker_sentiment_label": "Neutral"}, {"ticker": "CG", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004364", "ticker_sentiment_label": "Neutral"}, {"ticker": "VISL", "relevance_score": "0.008154", "ticker_sentiment_score": "-5e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACH", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.395308", "ticker_sentiment_label": "Bearish"}, {"ticker": "KWR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000976", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFSL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.247623", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "YSG", "relevance_score": "0.008154", "ticker_sentiment_score": "0.008962", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.013271", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006627", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00711", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFFN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.011011", "ticker_sentiment_label": "Neutral"}, {"ticker": "JVA", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004946", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "MHLD", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.023057", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.008154", "ticker_sentiment_score": "0.009176", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003447", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004146", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.041748", "ticker_sentiment_label": "Neutral"}, {"ticker": "DD", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.218942", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VMW", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.288544", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZNTL", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002221", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.02324", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLGY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003176", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003646", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVOS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003293", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRNT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.017712", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYMT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.268454", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "XRAY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.051801", "ticker_sentiment_label": "Neutral"}, {"ticker": "EB", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004311", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCN", "relevance_score": "0.008154", "ticker_sentiment_score": "8.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003261", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMCC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.379085", "ticker_sentiment_label": "Bearish"}, {"ticker": "STSS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00571", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEJU", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00019", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.008154", "ticker_sentiment_score": "0.033921", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEK", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.002684", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.008919", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000701", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001811", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBCP", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00532", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMK", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001063", "ticker_sentiment_label": "Neutral"}, {"ticker": "FB", "relevance_score": "0.008154", "ticker_sentiment_score": "0.057474", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.006978", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFG", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000514", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVFY", "relevance_score": "0.008154", "ticker_sentiment_score": "0.028397", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLOW", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.357947", "ticker_sentiment_label": "Bearish"}, {"ticker": "IVR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001088", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.013762", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006623", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.028533", "ticker_sentiment_score": "-0.042466", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.008154", "ticker_sentiment_score": "0.008568", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRWG", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002623", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000245", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.034222", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUNA", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00173", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005115", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.014059", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.011477", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVPT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000687", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNLX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.009494", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.044342", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000553", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXTI", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.149412", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.027386", "ticker_sentiment_label": "Neutral"}, {"ticker": "USNA", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001733", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000212", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006381", "ticker_sentiment_label": "Neutral"}, {"ticker": "VQS", "relevance_score": "0.008154", "ticker_sentiment_score": "-2.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.008154", "ticker_sentiment_score": "0.007588", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001807", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.008492", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGHT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004805", "ticker_sentiment_label": "Neutral"}, {"ticker": "ODC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.010558", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNST", "relevance_score": "0.008154", "ticker_sentiment_score": "0.013852", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.002401", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.008154", "ticker_sentiment_score": "0.007175", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.019229", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFBC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.007887", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000212", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTHR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.032636", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005914", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000485", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSV", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00174", "ticker_sentiment_label": "Neutral"}, {"ticker": "IR", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001113", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.004077", "ticker_sentiment_score": "0.017003", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.054391", "ticker_sentiment_label": "Neutral"}, {"ticker": "YTEN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.005052", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKOH", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001927", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001964", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.008154", "ticker_sentiment_score": "0.053992", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005338", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.156437", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NGMS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000839", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001716", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.044823", "ticker_sentiment_score": "0.001998", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.005114", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001929", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPC", "relevance_score": "0.008154", "ticker_sentiment_score": "0.004503", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003016", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.012034", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.008227", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.004077", "ticker_sentiment_score": "0.008693", "ticker_sentiment_label": "Neutral"}, {"ticker": "AJX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.357016", "ticker_sentiment_label": "Bullish"}, {"ticker": "FOXF", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003475", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.008154", "ticker_sentiment_score": "0.053083", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.039378", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.008154", "ticker_sentiment_score": "0.026783", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMI", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00035", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.015557", "ticker_sentiment_label": "Neutral"}, {"ticker": "JANX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001484", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOSS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.325912", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLSE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.005615", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTR", "relevance_score": "0.008154", "ticker_sentiment_score": "0.007252", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPLD", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.007051", "ticker_sentiment_label": "Neutral"}, {"ticker": "IART", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000918", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.002496", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.008154", "ticker_sentiment_score": "-5.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNRC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.008057", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.012089", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001196", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.33431", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CREX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000967", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.009934", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003328", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.0139", "ticker_sentiment_label": "Neutral"}, {"ticker": "OFLX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.042818", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001374", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003812", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIFY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.012084", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFVN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000501", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.01146", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.007589", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.004077", "ticker_sentiment_score": "0.039418", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDLS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.054945", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.002601", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRTX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.289582", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CTLT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004408", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.004077", "ticker_sentiment_score": "0.002214", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRKR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004554", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002875", "ticker_sentiment_label": "Neutral"}, {"ticker": "MX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.011497", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAKE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.009624", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.021919", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.047559", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGEN", "relevance_score": "0.008154", "ticker_sentiment_score": "0.007205", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004983", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNST", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.018166", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHTR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004792", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNPO", "relevance_score": "0.008154", "ticker_sentiment_score": "0.007092", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00537", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.02283", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.041655", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003863", "ticker_sentiment_label": "Neutral"}, {"ticker": "AROW", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000209", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000348", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.050324", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.1678", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GTBP", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.007087", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.016307", "ticker_sentiment_score": "-0.080489", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.019022", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.006189", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNUS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.051163", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMPT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.004701", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRKR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.006522", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.024235", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFSB", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001507", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.010495", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003862", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00319", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAYW", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.008305", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005604", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004095", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIXX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.026875", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.212629", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LEV", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000464", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000255", "ticker_sentiment_label": "Neutral"}, {"ticker": "APP", "relevance_score": "0.01223", "ticker_sentiment_score": "0.010442", "ticker_sentiment_label": "Neutral"}, {"ticker": "FEIM", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004584", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.016085", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.011436", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.013598", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIASP", "relevance_score": "0.004077", "ticker_sentiment_score": "-0.001153", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.017938", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.011947", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.009377", "ticker_sentiment_label": "Neutral"}, {"ticker": "DENN", "relevance_score": "0.008154", "ticker_sentiment_score": "-4.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.008838", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003958", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.224259", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EBET", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.005006", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPXC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00028", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUP", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005449", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.016439", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003911", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAII", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.043157", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACK", "relevance_score": "0.008154", "ticker_sentiment_score": "0.010815", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARR", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00265", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONB", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.005538", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.002745", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001953", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.35008", "ticker_sentiment_label": "Bearish"}, {"ticker": "IXHL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.024815", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.008154", "ticker_sentiment_score": "0.068015", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.011395", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.009764", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.005699", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002845", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003086", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002893", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAB", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.010381", "ticker_sentiment_label": "Neutral"}, {"ticker": "COHU", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003935", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004446", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.007073", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002694", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.229848", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RIOT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.029779", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLFC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.021564", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAAS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.05168", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNH", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.038977", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.056957", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002629", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001084", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.006465", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005092", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.031774", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPAY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000638", "ticker_sentiment_label": "Neutral"}, {"ticker": "UIHC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00455", "ticker_sentiment_label": "Neutral"}, {"ticker": "YETI", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004624", "ticker_sentiment_label": "Neutral"}, {"ticker": "VC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004012", "ticker_sentiment_label": "Neutral"}, {"ticker": "RWT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.315165", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SWIM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000538", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00802", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.012396", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005245", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000362", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.013364", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.010847", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.004032", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBUC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.032888", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBUU", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.002101", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.008154", "ticker_sentiment_score": "0.007843", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000995", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.004077", "ticker_sentiment_score": "0.000514", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.002304", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOCS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.009779", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000192", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005301", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00256", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLB", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003467", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.008154", "ticker_sentiment_score": "0.007033", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOMO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.010234", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPRO", "relevance_score": "0.008154", "ticker_sentiment_score": "0.009626", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005912", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.012683", "ticker_sentiment_label": "Neutral"}, {"ticker": "PUK", "relevance_score": "0.008154", "ticker_sentiment_score": "0.062866", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.010561", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.012854", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTIM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.388377", "ticker_sentiment_label": "Bullish"}, {"ticker": "WPRT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.004052", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006176", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.004077", "ticker_sentiment_score": "0.000514", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.004077", "ticker_sentiment_score": "0.002875", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.265908", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OTRK", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.015745", "ticker_sentiment_label": "Neutral"}, {"ticker": "REKR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.328258", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ANPC", "relevance_score": "0.016307", "ticker_sentiment_score": "0.018988", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.006748", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.008154", "ticker_sentiment_score": "0.01222", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004881", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBC", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001537", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000518", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMS", "relevance_score": "0.008154", "ticker_sentiment_score": "1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.032606", "ticker_sentiment_score": "0.000254", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.009512", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXC", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00525", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPW", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000327", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001705", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.015341", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003548", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000815", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.280001", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HYRE", "relevance_score": "0.008154", "ticker_sentiment_score": "0.011484", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEG", "relevance_score": "0.008154", "ticker_sentiment_score": "0.029648", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00135", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004038", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDEX", "relevance_score": "0.01223", "ticker_sentiment_score": "0.012396", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRCL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.340216", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CTXR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.018674", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.004077", "ticker_sentiment_score": "-0.007691", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003139", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEN", "relevance_score": "0.008154", "ticker_sentiment_score": "0.017459", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNPR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.029059", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBF", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.002995", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005266", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPL", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006433", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001346", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGTI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00707", "ticker_sentiment_label": "Neutral"}, {"ticker": "OOMA", "relevance_score": "0.008154", "ticker_sentiment_score": "0.018478", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOXX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002494", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.006478", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOUT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.014149", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.013641", "ticker_sentiment_label": "Neutral"}, {"ticker": "COOK", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006202", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.034333", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.008154", "ticker_sentiment_score": "0.009974", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDNT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.013397", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRGA", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005881", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.250531", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SITE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.014513", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.001695", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.008154", "ticker_sentiment_score": "0.008287", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIL", "relevance_score": "0.01223", "ticker_sentiment_score": "0.000634", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.030228", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGCP", "relevance_score": "0.008154", "ticker_sentiment_score": "0.001438", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.017416", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZME", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002706", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.010333", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.281863", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "USAU", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.019883", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNNE", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.336725", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZBRA", "relevance_score": "0.008154", "ticker_sentiment_score": "0.012513", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00327", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORTX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.006767", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.00251", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEV", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.031721", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.050564", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHG", "relevance_score": "0.008154", "ticker_sentiment_score": "0.004277", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.016641", "ticker_sentiment_label": "Neutral"}, {"ticker": "UEIC", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000414", "ticker_sentiment_label": "Neutral"}, {"ticker": "URBN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.204581", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RMAX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006102", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSAT", "relevance_score": "0.008154", "ticker_sentiment_score": "2.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBK", "relevance_score": "0.008154", "ticker_sentiment_score": "0.017108", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.003038", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002197", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.008154", "ticker_sentiment_score": "0.077993", "ticker_sentiment_label": "Neutral"}, {"ticker": "MUX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.008972", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYLA", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.024305", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.005751", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLYS", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.004257", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAMI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002118", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIND", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.255591", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MYGN", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.286303", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TACT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002245", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002833", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.008154", "ticker_sentiment_score": "0.005477", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCS", "relevance_score": "0.008154", "ticker_sentiment_score": "0.034157", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.004077", "ticker_sentiment_score": "-0.012433", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.029797", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWTX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.008853", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTG", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.26087", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AGIO", "relevance_score": "0.008154", "ticker_sentiment_score": "0.000479", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.008154", "ticker_sentiment_score": "0.020043", "ticker_sentiment_label": "Neutral"}, {"ticker": "UFI", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.017291", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTEX", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.23831", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "XLO", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.409365", "ticker_sentiment_label": "Bearish"}, {"ticker": "KBAL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.01138", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.008154", "ticker_sentiment_score": "0.002595", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETWO", "relevance_score": "0.008154", "ticker_sentiment_score": "0.003211", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.008154", "ticker_sentiment_score": "0.098732", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAK", "relevance_score": "0.008154", "ticker_sentiment_score": "0.00653", "ticker_sentiment_label": "Neutral"}, {"ticker": "YORW", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.000473", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPR", "relevance_score": "0.008154", "ticker_sentiment_score": "4.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBNH", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.01226", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.008154", "ticker_sentiment_score": "0.008371", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.261946", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALTR", "relevance_score": "0.008154", "ticker_sentiment_score": "0.006386", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.008154", "ticker_sentiment_score": "5.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEL", "relevance_score": "0.008154", "ticker_sentiment_score": "-0.013657", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCL", "relevance_score": "0.008154", "ticker_sentiment_score": "0.009624", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:BGN", "relevance_score": "0.004077", "ticker_sentiment_score": "-0.000464", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.004077", "ticker_sentiment_score": "0.002694", "ticker_sentiment_label": "Neutral"}]}, {"title": "51 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/04/26492531/51-biggest-movers-from-yesterday", "time_published": "20220406T073509", "authors": [], "summary": "Gainers\nSunshine Biopharma, Inc.   ( NASDAQ: SBFM )  shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.\nAnghami Inc.  ( NASDAQ: ANGH )  gained 47.5% to close at $13.41.\nDingd", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_427.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.012037, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "INZY", "relevance_score": "0.073773", "ticker_sentiment_score": "0.010783", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBD", "relevance_score": "0.073773", "ticker_sentiment_score": "0.002646", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVOS", "relevance_score": "0.110462", "ticker_sentiment_score": "0.003292", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZSAN", "relevance_score": "0.110462", "ticker_sentiment_score": "-0.04751", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.036926", "ticker_sentiment_score": "0.010576", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYI", "relevance_score": "0.073773", "ticker_sentiment_score": "0.00135", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNSP", "relevance_score": "0.110462", "ticker_sentiment_score": "0.005244", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRGV", "relevance_score": "0.073773", "ticker_sentiment_score": "0.00262", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENSC", "relevance_score": "0.110462", "ticker_sentiment_score": "-0.000151", "ticker_sentiment_label": "Neutral"}, {"ticker": "WKSP", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001348", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSN", "relevance_score": "0.073773", "ticker_sentiment_score": "-0.001146", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.073773", "ticker_sentiment_score": "0.000273", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLG", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001222", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGF", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001131", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPO", "relevance_score": "0.073773", "ticker_sentiment_score": "0.003185", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLPN", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001151", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCUS", "relevance_score": "0.110462", "ticker_sentiment_score": "0.010576", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCC", "relevance_score": "0.073773", "ticker_sentiment_score": "0.002777", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.073773", "ticker_sentiment_score": "0.006012", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGNT", "relevance_score": "0.073773", "ticker_sentiment_score": "-0.483784", "ticker_sentiment_label": "Bearish"}, {"ticker": "IMTE", "relevance_score": "0.073773", "ticker_sentiment_score": "0.000118", "ticker_sentiment_label": "Neutral"}, {"ticker": "SABS", "relevance_score": "0.073773", "ticker_sentiment_score": "0.003515", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001765", "ticker_sentiment_label": "Neutral"}, {"ticker": "TANH", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001543", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.073773", "ticker_sentiment_score": "0.003046", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGLY", "relevance_score": "0.073773", "ticker_sentiment_score": "0.004905", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISBC", "relevance_score": "0.036926", "ticker_sentiment_score": "0.010576", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTP", "relevance_score": "0.073773", "ticker_sentiment_score": "0.000345", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.073773", "ticker_sentiment_score": "0.006635", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLXA", "relevance_score": "0.073773", "ticker_sentiment_score": "0.006076", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDL", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001185", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001393", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASUR", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001836", "ticker_sentiment_label": "Neutral"}, {"ticker": "DWAC", "relevance_score": "0.073773", "ticker_sentiment_score": "0.002595", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBS", "relevance_score": "0.110462", "ticker_sentiment_score": "0.002551", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVE", "relevance_score": "0.073773", "ticker_sentiment_score": "0.014033", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.073773", "ticker_sentiment_score": "0.002405", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.073773", "ticker_sentiment_score": "0.000762", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPOF", "relevance_score": "0.073773", "ticker_sentiment_score": "0.000623", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPX", "relevance_score": "0.073773", "ticker_sentiment_score": "0.008925", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.110462", "ticker_sentiment_score": "0.009171", "ticker_sentiment_label": "Neutral"}, {"ticker": "VASO", "relevance_score": "0.036926", "ticker_sentiment_score": "-0.035661", "ticker_sentiment_label": "Neutral"}, {"ticker": "GWGH", "relevance_score": "0.073773", "ticker_sentiment_score": "0.001784", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.073773", "ticker_sentiment_score": "0.049562", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMRA", "relevance_score": "0.073773", "ticker_sentiment_score": "-0.035661", "ticker_sentiment_label": "Neutral"}, {"ticker": "SST", "relevance_score": "0.073773", "ticker_sentiment_score": "0.052752", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.073773", "ticker_sentiment_score": "0.009976", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAI", "relevance_score": "0.073773", "ticker_sentiment_score": "0.003113", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.110462", "ticker_sentiment_score": "0.004301", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLG", "relevance_score": "0.073773", "ticker_sentiment_score": "0.00697", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.073773", "ticker_sentiment_score": "0.00303", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNH", "relevance_score": "0.036926", "ticker_sentiment_score": "0.006355", "ticker_sentiment_label": "Neutral"}]}, {"title": "12 Health Care Stocks Moving In Tuesday's Intraday Session", "url": "https://www.benzinga.com/intraday-update/22/04/26482920/12-health-care-stocks-moving-in-tuesdays-intraday-session", "time_published": "20220405T181603", "authors": [], "summary": "Gainers\nSunshine Biopharma  ( NASDAQ:SBFM )  shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7 million, which is 5279.3% of its average full-day volume over the last 100 days. The company's market cap stands at $38.9 million.\nComp", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_5899.jpeg", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.897321"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.01569, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LGVN", "relevance_score": "0.070809", "ticker_sentiment_score": "0.000436", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.070809", "ticker_sentiment_score": "0.009531", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMRA", "relevance_score": "0.070809", "ticker_sentiment_score": "-0.001788", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLG", "relevance_score": "0.070809", "ticker_sentiment_score": "0.00092", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNSP", "relevance_score": "0.070809", "ticker_sentiment_score": "0.00156", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCUS", "relevance_score": "0.070809", "ticker_sentiment_score": "0.000844", "ticker_sentiment_label": "Neutral"}, {"ticker": "SABS", "relevance_score": "0.070809", "ticker_sentiment_score": "-0.008964", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZSAN", "relevance_score": "0.070809", "ticker_sentiment_score": "-0.000167", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPX", "relevance_score": "0.070809", "ticker_sentiment_score": "0.002143", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.070809", "ticker_sentiment_score": "-0.039757", "ticker_sentiment_label": "Neutral"}]}, {"title": "30 Stocks Moving In Tuesday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/04/26480745/30-stocks-moving-in-tuesdays-mid-day-session", "time_published": "20220405T161259", "authors": [], "summary": "Gainers\nSunshine Biopharma, Inc.   ( NASDAQ: SBFM )  shares jumped 139% to $5.40 after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.\nSystem1, Inc.  ( NYSE: SST )  climbed 45% to $23.93 as the company reported a 48% year-over-", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_155.jpg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.025536, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISBC", "relevance_score": "0.066432", "ticker_sentiment_score": "0.004313", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTP", "relevance_score": "0.132404", "ticker_sentiment_score": "0.00039", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.132404", "ticker_sentiment_score": "0.003624", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDL", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.066432", "ticker_sentiment_score": "0.004313", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASUR", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000466", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYI", "relevance_score": "0.132404", "ticker_sentiment_score": "0.001048", "ticker_sentiment_label": "Neutral"}, {"ticker": "DWAC", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000217", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBS", "relevance_score": "0.197466", "ticker_sentiment_score": "-0.000518", "ticker_sentiment_label": "Neutral"}, {"ticker": "WKSP", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000313", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.132404", "ticker_sentiment_score": "-0.000165", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPO", "relevance_score": "0.132404", "ticker_sentiment_score": "-0.000576", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPOF", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000297", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCUS", "relevance_score": "0.197466", "ticker_sentiment_score": "0.004313", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.197466", "ticker_sentiment_score": "0.009641", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCC", "relevance_score": "0.132404", "ticker_sentiment_score": "-8.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "VASO", "relevance_score": "0.066432", "ticker_sentiment_score": "-0.043679", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.132404", "ticker_sentiment_score": "0.061782", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMRA", "relevance_score": "0.132404", "ticker_sentiment_score": "-0.043679", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000269", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIL", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000288", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGNT", "relevance_score": "0.132404", "ticker_sentiment_score": "-0.489972", "ticker_sentiment_label": "Bearish"}, {"ticker": "SST", "relevance_score": "0.132404", "ticker_sentiment_score": "0.003548", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.132404", "ticker_sentiment_score": "0.002413", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMTE", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000222", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLG", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000667", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000691", "ticker_sentiment_label": "Neutral"}, {"ticker": "SABS", "relevance_score": "0.132404", "ticker_sentiment_score": "0.001152", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.132404", "ticker_sentiment_score": "0.000689", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNH", "relevance_score": "0.066432", "ticker_sentiment_score": "-0.00557", "ticker_sentiment_label": "Neutral"}]}, {"title": "ImmixBio Management Discusses Key Milestones, Drug Development Timelines and the IMMX Advantage at IMMX Milestone Day Event Held on April 5, 2022", "url": "https://www.globenewswire.com/news-release/2022/04/05/2416803/0/en/ImmixBio-Management-Discusses-Key-Milestones-Drug-Development-Timelines-and-the-IMMX-Advantage-at-IMMX-Milestone-Day-Event-Held-on-April-5-2022.html", "time_published": "20220405T133000", "authors": ["Immix Biopharma", "Inc."], "summary": "LOS ANGELES, April  05, 2022   ( GLOBE NEWSWIRE )  -- Immix Biopharma, Inc.  ( Nasdaq: IMMX )   ( \"ImmixBio\" or the \"Company\" ) , a biopharmaceutical company pioneering Tissue Specific Therapeutics  ( TSTx ) TM targeting oncology and immuno-dysregulated diseases, today announced that management disc", "banner_image": "https://ml.globenewswire.com/Resource/Download/005f353d-f44d-4ef3-9af0-5e321adda1de?size=2", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.026114, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.635246", "ticker_sentiment_score": "0.026114", "ticker_sentiment_label": "Neutral"}]}, {"title": "ImmixBio Management Discusses Key Milestones, Drug Development Timelines and the IMMX Advantage at IMMX Milestone Day Event Held on April 5, 2022", "url": "https://www.benzinga.com/pressreleases/22/04/g26475010/immixbio-management-discusses-key-milestones-drug-development-timelines-and-the-immx-advantage-at-", "time_published": "20220405T133000", "authors": ["Globe Newswire"], "summary": "The IMMX Milestone Day Event is viewable at www.immixbio.com/Apr2022MilestoneDay\nManagement discussed financial position, milestones, and new opportunities presented by current market volatility\nImmixBio plans to commence 2 clinical trials in 2022\nLOS ANGELES, April  05, 2022   ( GLOBE NEWSWIRE )  -", "banner_image": "https://ml.globenewswire.com/media/b46d5687-65de-44df-81d5-e36f2665d8e7/small/immix-logonew-gray-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.088593, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMMX", "relevance_score": "0.59928", "ticker_sentiment_score": "0.020603", "ticker_sentiment_label": "Neutral"}]}]}